syndrome	score	normalized_score
DRAVET SYNDROME	2.948203	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	85.50092547901214
AURICULOCONDYLAR SYNDROME	2.333878554	79.16274944432253
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.14424481624908
TOWNES-BROCKS SYNDROME 1; TBS1	1.713722434	58.12769453121105
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.6684777039999998	56.593040031503925
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	1.6451757189999998	55.80266077335922
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.5640232699999999	53.05005354108926
CORNELIA DE LANGE SYNDROME 1	1.509313349	51.19434954105942
OROFACIODIGITAL SYNDROME TYPE 4	1.350545554	45.8091099561326
MYOCLONIC-ASTASTIC EPILEPSY	1.344235154	45.59506770734579
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.31295385	44.53403819207836
PALLISTER-HALL SYNDROME	1.280121434	43.42039656020973
LENNOX-GASTAUT SYNDROME	1.2670541100000001	42.97716642985575
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	1.2554224890000003	42.5826338620509
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	40.488867286275735
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.1641561139999999	39.48697270846003
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	39.07859329903674
ALLAN-HERNDON-DUDLEY SYNDROME	1.13217389	38.40216871090627
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1292528	38.30308835585609
EARLOBE CREASE	1.125	38.158837773382636
TRISOMY 8P	1.1033231989999999	37.42358307755605
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.1014010799999998	37.3583867867986
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.081343814	36.67806504504609
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686936999999999	36.248986246876484
SLC35A2-CDG	1.052819604	35.710553309931505
BENIGN OCCIPITAL EPILEPSY	1.027027	34.8356948283412
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	1.022863704	34.69448012908202
ROLANDIC EPILEPSY	1.021574	34.650734701782746
JOUBERT SYNDROME 1	1.016462574	34.4773604124275
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	1.0151217989999999	34.43188270956918
RETT SYNDROME; RTT	1.010342529	34.269774808586796
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00689655	34.15289076091436
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.001086973	33.95583591089216
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	33.91896690967345
EARRING HOLES, NATURAL	1.0	33.91896690967345
CRYPTOTIA, FAMILIAL	1.0	33.91896690967345
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	33.91896690967345
HAIRY EARS	1.0	33.91896690967345
HEREDITARY ANGIOEDEMA TYPE 1	1.0	33.91896690967345
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	1.0	33.91896690967345
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	33.91896690967345
RELAPSING POLYCHONDRITIS	1.0	33.91896690967345
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	31.8122273127054
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.23057842353461
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.9172414	31.111880694782553
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.8999999999999999	30.527070218706104
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8876050639999999	30.106646794674585
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.842211884	28.566957024329735
LAFORA DISEASE	0.78884221	26.75671281794368
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.138535914928518
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	25.758348729717735
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750931904	25.470834403194083
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.74700873	25.337764394107193
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	24.392676284502798
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.7	23.743276836771415
XQ12-Q13.3 DUPLICATION SYNDROME	0.68797398	23.335366662336344
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.6844867539999999	23.21708355903579
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.683184133	23.17290000044095
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.6749447700000001	22.89342931948716
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	22.843224635481345
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.672369074	22.806064372093783
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.666667	22.612655912771274
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644	21.937580281954805
SPINOCEREBELLAR ATAXIA TYPE 10	0.62473414	21.190336622003304
BILATERAL POLYMICROGYRIA	0.6240021039999999	21.16550671714261
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.61220798	20.765462215458026
CENTRALOPATHIC EPILEPSY	0.6047009	20.510829817349755
TRISOMY 18	0.602176874	20.4252174629766
ADNP SYNDROME	0.598979939	20.31678073049922
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5967571999999999	20.24138771990938
SCALP-EAR-NIPPLE SYNDROME	0.58473095	19.83346974411192
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.5840166	19.809239730099996
SCALP-EAR-NIPPLE SYNDROME; SENS	0.5796563499999999	19.66134455463209
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.57496951	19.50237178376116
PERIORAL MYOCLONIA WITH ABSENCES	0.56570971	19.188288933970966
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.550630819	18.676828529107393
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5428161300000001	18.411762351507004
BRACHYDACTYLY TYPE A2	0.537037	18.215740232270303
OTOONYCHOPERONEAL SYNDROME	0.5353489699999999	18.158483998557763
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.090104378836873
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.5275337800000001	17.893400827554956
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	17.87621137350447
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.5259578189999999	17.83994585854502
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.68941840165009
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.516670419	17.52492684526812
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.515625	17.489467312800375
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.514004494	17.434501423409447
PETERS-PLUS SYNDROME; PTRPLS	0.5128741330000001	17.396160746054466
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.512368214	17.379000496234486
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.507846503	17.225628730450378
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.198349299556376
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.506888193	17.19312384527117
PETERS PLUS SYNDROME	0.506868234	17.192446856610623
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.50512821	17.13342704013258
DISTAL MYOTILINOPATHY	0.50492611	17.12657201692014
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5027027	17.0511562467035
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.50235294	17.039292748837173
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.501086973	16.996352456055437
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	16.977988082910166
MEDULLOBLASTOMA	0.500545554	16.977988082910166
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	16.977847827981996
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	16.977847827981996
PAROXYSMAL HEMICRANIA	0.5	16.959483454836725
CREST SYNDROME	0.5	16.959483454836725
PYKNOACHONDROGENESIS	0.5	16.959483454836725
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	16.959483454836725
INHALATIONAL ANTHRAX	0.5	16.959483454836725
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	16.959483454836725
BRACHYDACTYLY TYPE C	0.5	16.959483454836725
BRACHYDACTYLY, TYPE D	0.5	16.959483454836725
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	16.959483454836725
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	16.959483454836725
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	16.959483454836725
MADELUNG DEFORMITY	0.5	16.959483454836725
POLAND SYNDROME	0.4888886	16.58259624591658
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.48631315	16.495239642589063
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.366500542873062
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.47424667000000004	16.085957106752826
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44171742	14.982598552406332
MYOCLONIC EPILEPSY OF INFANCY	0.43886191399999996	14.885742738881955
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.43886191399999996	14.885742738881955
PSEUDOAMINOPTERIN SYNDROME	0.43367648400000003	14.709858310299529
CZEIZEL-LOSONCI SYNDROME	0.43333299999999997	14.698207687869525
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.41217954	13.980704178104425
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40699811999999996	13.804955764579304
BECKWITH-WIEDEMANN SYNDROME	0.4061966	13.777769034221865
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.40208787	13.638405157311082
NEUROFACIODIGITORENAL SYNDROME	0.40031170000000005	13.578159305855127
DISTAL MONOSOMY 12Q	0.394864554	13.393397740928966
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3883056	13.170924797240897
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.383358539	13.00312559888176
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.380952	12.921498282173921
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.37778141899999995	12.81395545015048
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36420503000000004	12.353458360906629
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35752487	12.126874234915302
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.126629679163884
SPINOCEREBELLAR ATAXIA TYPE 42	0.35743284	12.123752672390605
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.350022833	11.872412890157156
GLOMUVENOUS MALFORMATION	0.35	11.871638418385707
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.34948424299999997	11.854144473769274
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.346615073	11.756825191481047
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.346069519	11.738320563407607
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.71469040632548
NON-DISTAL MONOSOMY 20Q	0.344083579	11.67095953026301
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.342711979	11.624436275249703
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.34166633	11.588968941419571
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.54517684162183
FRAXE INTELLECTUAL DISABILITY	0.34017264999999997	11.538304858925928
MARTSOLF SYNDROME	0.33947207	11.51454190908835
FG SYNDROME 2; FGS2	0.33879748	11.491660513200754
PRIMROSE SYNDROME; PRIMS	0.33872228	11.489109806889147
KEUTEL SYNDROME; KTLS	0.337458649	11.446248748814108
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.335509874	11.38014831407471
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.334419973	11.343179998120888
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.33395510400000006	11.327412121892559
COG4-CDG	0.333878554	11.32481562497562
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.32467537004745
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.32467537004745
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.30631099690218
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	11.30631099690218
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.30631099690218
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.333333	11.30631099690218
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	11.30631099690218
PLACENTAL INSUFFICIENCY	0.333333	11.30631099690218
BRACHYDACTYLY, TYPE A6	0.333333	11.30631099690218
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	11.30631099690218
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.327464519	11.107258184053133
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32742392	11.105881107915568
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.088893810907866
RING CHROMOSOME 7 SYNDROME	0.32036969	10.866608913972343
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.31529217	10.694384681109137
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.31314179999999997	10.621446352235582
JUVENILE MYOCLONIC EPILEPSY	0.3123459	10.594450246472174
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.30897985	10.480277307905867
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.30157221999999995	10.229018151056762
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.219154311965626
SCHINZEL-GIEDION SYNDROME	0.29864470000000004	10.129719697049357
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.298125454	10.112107409157375
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.023692873251942
CHROMOSOME 1P36 DELETION SYNDROME	0.294566473	9.991390450386218
SAETHRE-CHOTZEN SYNDROME	0.29416119899999993	9.977643974990865
ABLEPHARON-MACROSTOMIA SYNDROME	0.2911642	9.875988865081544
OTOONYCHOPERONEAL SYNDROME	0.28061503	9.518171916927024
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.27400614399999995	9.294005331383218
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.26975159400000004	9.14969539071767
ZIMMERMANN-LABAND SYNDROME	0.269013469	9.124658953267465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.268915084	9.12132183570806
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.2659091	9.01936196388105
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.26196832000000003	8.885694777462747
LANDAU-KLEFFNER SYNDROME	0.259858903	8.814145532041042
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.259541069	8.803364931112274
8Q24.3 MICRODELETION SYNDROME	0.257848933	8.745969426121606
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25693326	8.714910743934526
20Q13.33 MICRODELETION SYNDROME	0.25668048899999996	8.7063370127498
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25564458	8.671200049657369
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25531915	8.660161800255953
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.624694432506852
LAING EARLY-ONSET DISTAL MYOPATHY	0.25344828	8.596703822633653
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.546380286567784
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535	8.533175971939515
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535	8.533175971939515
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.51661072863707
EAR-PATELLA-SHORT STATURE SYNDROME	0.250545554	8.498246355491803
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.49810610056363
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	8.479741727418363
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	8.479741727418363
VACTERL WITH HYDROCEPHALUS	0.25	8.479741727418363
HYPERPARATHYROIDISM 2	0.25	8.479741727418363
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	8.479741727418363
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	8.479741727418363
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	8.479741727418363
DYSTONIA 6, TORSION	0.25	8.479741727418363
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.244961144	8.308828937491754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.24384053608249
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.239721884	8.131118650920579
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23932652	8.1177083124873
KOOLEN-DE VRIES SYNDROME; KDVS	0.238957923	8.105205883041297
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	7.957891773395523
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23387798	7.93289946452127
8Q22.1 MICRODELETION SYNDROME	0.23192199400000002	7.866554440111486
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.22901783	7.76804819749522
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.226086973	7.668636555895235
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	7.663283362780652
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.225545554	7.650272182749967
BRANCHIOOCULOFACIAL SYNDROME	0.224379069	7.610706216634336
PIERPONT SYNDROME	0.22318961299999998	7.570361097929823
CODAS SYNDROME	0.222744554	7.555265156435972
DISTAL 17P13.1 MICRODELETION SYNDROME	0.22135945	7.508283859693515
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.22098719400000003	7.495657320747588
DOWN SYNDROME	0.22033085	7.473394810330225
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.219299039	7.438396847164189
CLASSICAL EHLERS-DANLOS SYNDROME	0.21898046	7.427590976605071
AURICULOOSTEODYSPLASIA	0.21787023	7.389933121972944
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.21740343	7.374099748219509
COHEN-GIBSON SYNDROME; COGIS	0.217252574	7.368982868547383
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.216853483	7.355446114124435
WARBURG MICRO SYNDROME 2; WARBM2	0.21619997000000002	7.333279628302394
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.215078889	7.295253718960329
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.214545704	7.277168634588596
8P INVERTED DUPLICATION/DELETION SYNDROME	0.21349769899999999	7.2416213876724225
INTELLECTUAL DISABILITY, WOLFF TYPE	0.21349769899999999	7.2416213876724225
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.21237721	7.20361555835877
FGFR2-RELATED BENT BONE DYSPLASIA	0.21175792000000002	7.182609881341278
DEND SYNDROME	0.209883219	7.119021960156748
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2098612	7.118275098424362
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.208107573	7.058793882239452
SHELDON-HALL SYNDROME	0.20742912	7.035781457382684
BRANCHIOSKELETOGENITAL SYNDROME	0.20662026900000002	7.008346067078828
KAGAMI-OGATA SYNDROME	0.20640612300000002	7.001082455990989
NEONATAL MARFAN SYNDROME	0.20612263	6.991466666304865
RENPENNING SYNDROME	0.205756969	6.979063822945706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.205467529	6.96924631716337
FAMILIAL LAMBDOID SYNOSTOSIS	0.20546448	6.9691428982332635
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.20540101000000002	6.966990061403506
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.20505564	6.955275467801912
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.20492611000000002	6.950881944018103
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.204129784	6.923871388774789
MOMO SYNDROME	0.20397778900000002	6.9187158753993545
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.20376969	6.911657372304418
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.20368050000000001	6.908632139645745
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.900755477149979
CODAS SYNDROME	0.203439913	6.900471677153846
XQ25 MICRODUPLICATION SYNDROME	0.20271829300000002	6.875995072252489
DISTAL TRISOMY 6P	0.20218238400000002	6.857817592614893
RING CHROMOSOME 8 SYNDROME	0.20163132	6.83912607103378
1P21.3 MICRODELETION SYNDROME	0.20054555400000001	6.802298010008132
BECKWITH-WIEDEMANN SYNDROME	0.2	6.783793381934691
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	6.783793381934691
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.783793381934691
RADIATION PROCTITIS	0.2	6.783793381934691
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	6.783793381934691
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	6.783793381934691
EAR PITS, POSTERIOR HELICAL	0.2	6.783793381934691
MUCKLE-WELLS SYNDROME	0.19444430000000001	6.595349777474619
TOWNES-BROCKS SYNDROME	0.19050465	6.461720919488922
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18830818400000002	6.3872190619167
20Q11.2 MICRODUPLICATION SYNDROME	0.188182873	6.382968642254282
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.375616400905909
BRANCHIOGENIC DEAFNESS SYNDROME	0.1851855	6.281300846651333
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184140403	6.2458522360909345
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.18347613999999998	6.223321121374614
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.206102836202256
MOWAT-WILSON SYNDROME; MOWS	0.18263544899999998	6.194805751164353
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.177931234721626
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.078329205960376
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.17793815	6.0354782218185115
UNILATERAL POLYMICROGYRIA	0.17776204999999998	6.029505091745717
3MC SYNDROME	0.17750715	6.020859147080442
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.177243819	6.01192723160515
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.1769231	6.001048774456847
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.176753623	5.9953002897018965
MONOSOMY 9Q22.3	0.175463843	5.951552284561138
PFAPA SYNDROME	0.17543893000000002	5.9507072613385175
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.17465101400000002	5.923981964606916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.173769243	5.894073203236005
CEREBROOCULONASAL SYNDROME	0.17188255	5.8300785258002925
ROIFMAN SYNDROME; RFMN	0.17106678400000003	5.802408585840257
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.17086195	5.79546082817228
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.17027323000000003	5.775492053973218
MICROTRIPLICATION 11Q24.1	0.1693697	5.744845249801321
AREDYLD SYNDROME	0.16871618000000002	5.722678526546511
BRACHYDACTYLY, TYPE E	0.16871618000000002	5.722678526546511
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.16799087399999998	5.698076896333122
TARP SYNDROME	0.167382213	5.677431744014914
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.6715368310798135
BRACHYDACTYLY, TYPE B1	0.166667	5.653172457934546
268650 RUDIGER SYNDROME	0.166667	5.653172457934546
PITYRIASIS RUBRA PILARIS	0.166667	5.653172457934546
PEMPHIGUS VULGARIS	0.166667	5.653172457934546
AURICULOOSTEODYSPLASIA	0.166667	5.653172457934546
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	5.653172457934546
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	5.653172457934546
HOLT-ORAM SYNDROME	0.166667	5.653172457934546
BRACHYDACTYLY TYPE B2	0.166667	5.653172457934546
BRACHYDACTYLY TYPE E	0.166667	5.653172457934546
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.653172457934546
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.653172457934546
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	5.653172457934546
BRACHYDACTYLY TYPE B	0.166667	5.653172457934546
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	5.653172457934546
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	5.653172457934546
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	5.653172457934546
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	5.653172457934546
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	5.653172457934546
49,XYYYY SYNDROME	0.1666667	5.653162282244473
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.1666667	5.653162282244473
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.16594129999999999	5.628557463648195
JUVENILE ABSENCE EPILEPSY	0.16503685	5.597879454026742
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.163230184	5.5365992097559085
ATYPICAL RETT SYNDROME	0.162472419	5.510896603795601
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.410268560204301
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.410268560204301
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1594828	5.4094918158620695
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.1594828	5.4094918158620695
608028 THAI SYMPHALANGISM SYNDROME	0.15922215	5.400650837137063
MOWAT-WILSON SYNDROME	0.15751024899999996	5.342584923765425
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.299055390690532
DISTAL MONOSOMY 9P	0.155828444	5.285539835621903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.2539412652385185
TEEBI-SHALTOUT SYNDROME; TBSH	0.15466734000000001	5.246156387467214
CHARGE SYNDROME	0.15363909999999997	5.211279548932009
FEBRILE CONVULSIONS, FAMILIAL, 9	0.153624	5.210767372531675
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.178131017436723
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.159626389363282
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.15181360400000002	5.14936061051427
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.14891950999999998	5.051195931894784
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.0353825703318265
OLIVER SYNDROME	0.14795135	5.018356944891516
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.00349548521591
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.00349548521591
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.147406763	4.999885116459077
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.145058844	4.920246129591483
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.14415820300000004	4.889697317314989
PHACE SYNDROME	0.14394397299999998	4.882430857033928
ALG11-CDG	0.14394397299999998	4.882430857033928
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.143244119	4.858692532366327
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	4.84556185581522
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.84556185581522
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.84556185581522
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	4.84556185581522
GANGLIONEUROMA	0.14285699999999998	4.84556185581522
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.141153799	4.787791037455698
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.140625	4.7698547216728295
16P12.1P12.3 TRIPLICATION SYNDROME	0.14011800000000002	4.752657805449625
C SYNDROME	0.139121479	4.71885684262583
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.13790635899999998	4.677641227554547
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.137708673	4.670935922662042
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	4.666120480848842
ATYPICAL JUVENILE PARKINSONISM	0.137566179	4.666102673391215
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.13703700000000002	4.648153468400921
CHRISTIANSON SYNDROME	0.13649015000000003	4.629604881346367
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13553973	4.597367616816074
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.13549420399999998	4.595823421928544
ZECHI-CEIDE SYNDROME	0.13464094400000004	4.566881724223197
CONGENITAL MYASTHENIC SYNDROME	0.133985949	4.544664970492194
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.133985949	4.544664970492194
TEMTAMY SYNDROME; TEMTYS	0.132643903	4.499144156626936
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.457170486564189
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.454663196530225
EHLERS-DANLOS SYNDROME, TYPE I	0.13090481999999998	4.440156257896759
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.13081887	4.437240922690874
22Q11.2 MICRODUPLICATION SYNDROME	0.12952334299999999	4.393297985247284
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.129397449	4.389027790827158
LAURENCE-MOON SYNDROME	0.1286805	4.364709621420235
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.128380094	4.354520160246767
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.12750605899999998	4.32487379600387
HEART-HAND SYNDROME TYPE 2	0.12704918	4.309376932321147
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.12704918	4.309376932321147
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.12680505	4.301096294929488
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.126057584	4.275743020409382
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.125541419	4.25823523685445
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.125541419	4.25823523685445
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.125	4.239870863709181
PARKINSON DISEASE, LATE-ONSET; PD	0.125	4.239870863709181
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.125	4.239870863709181
PERRY SYNDROME	0.125	4.239870863709181
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.125	4.239870863709181
SECKEL SYNDROME	0.12497225000000001	4.238929612377438
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	4.199490333603215
TRISOMY XQ28	0.12359801	4.192316811291488
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.12318382900000002	4.178268219657874
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.12275444399999998	4.1637039240513625
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.12240386899999998	4.151812782227004
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12096990299999999	4.103174136923407
MENTAL RETARDATION, X-LINKED 21	0.12058098899999999	4.089982575826698
GALLOWAY-MOWAT SYNDROME	0.12045510299999998	4.085712652758307
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.119768013	4.06240726978434
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.118300879	4.0126436001862835
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.007636177020375
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.11810906400000001	4.0061374335485045
20P13 MICRODELETION SYNDROME	0.116629819	3.9559629713422044
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.11469522999999998	3.890343711067385
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.11469522999999998	3.890343711067385
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.113955543	3.865254292190871
XIA-GIBBS SYNDROME	0.113461604	3.848500391594473
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.11340077400000002	3.8464371008373583
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11316017999999999	3.8382764009126915
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11274232	3.8241030213998153
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.1121951	3.805541884327504
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.11182266	3.7929091042916654
MAST CELL SARCOMA	0.11111099999999999	3.7687703323007264
TETRAPLOIDY	0.11111099999999999	3.7687703323007264
STEINERT MYOTONIC DYSTROPHY	0.11111099999999999	3.7687703323007264
ULNAR-MAMMARY SYNDROME	0.11111099999999999	3.7687703323007264
TARP SYNDROME; TARPS	0.11053204400000001	3.74913274289457
14Q12 MICRODELETION SYNDROME	0.110282669	3.7406742005214704
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.11	3.7310863600640802
SAGLIKER SYNDROME	0.10961538000000001	3.7180404470112816
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.109075683	3.6997344823270315
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.10899505400000001	3.6969996299440715
SPINOCEREBELLAR ATAXIA TYPE 29	0.108777964	3.6896361614176505
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.10833333	3.6745546354847343
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.10793651000000001	3.661094911035638
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.107394603	3.6427139854345176
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.107320054	3.640185360370368
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.6364731329559064
NAGER SYNDROME	0.1071242	3.633542195025241
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	3.6211503753303296
MATERNAL PHENYLKETONURIA	0.106732113	3.6202430090465283
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10657480000000001	3.614907114605067
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.106155813	3.6006955084164827
MICROTIA	0.10531915	3.572316763804935
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.10492611	3.5589852530507566
TRISOMY 13	0.104648429	3.549566600400312
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.104129784	3.5319746978074438
AICARDI SYNDROME; AIC	0.1036867	3.516945746273239
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.103611889	3.5144082344397587
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.10358423	3.5134700697340047
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.10317752300000001	3.499674988459072
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.497187948048354
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.10270270000000001	3.4835694828341204
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.10270270000000001	3.4835694828341204
WEYERS ACROFACIAL DYSOSTOSIS	0.10204918	3.46140275957931
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10196464000000001	3.4585352501167663
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.10163132000000001	3.447229380066434
NON-DISTAL TRISOMY 13Q	0.1008403	3.4203987988615436
CONGENITAL TRACHEAL STENOSIS	0.10057470000000002	3.4113899212503354
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.100541419	3.4102610641126145
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.100541419	3.4102610641126145
LIPOID PROTEINOSIS	0.100541419	3.4102610641126145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.10023615000000001	3.3999066550030648
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.3918966909673456
ELLIS VAN CREVELD SYNDROME	0.1	3.3918966909673456
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1	3.3918966909673456
METAPHYSEAL ANADYSPLASIA	0.1	3.3918966909673456
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	3.3918966909673456
LICHEN PLANUS PEMPHIGOIDES	0.1	3.3918966909673456
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	3.3918966909673456
KAPOSI SARCOMA	0.1	3.3918966909673456
LEISHMANIASIS	0.1	3.3918966909673456
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.1	3.3918966909673456
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	3.3918966909673456
JUVENILE XANTHOGRANULOMA	0.1	3.3918966909673456
AA AMYLOIDOSIS	0.1	3.3918966909673456
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.099348799	3.3698086257967987
WITTEVEEN-KOLK SYNDROME	0.09905529300000002	3.3598532054950088
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.3563870601854755
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.337417877941241
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.3281917832659422
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.3281917832659422
49,XXXYY SYNDROME	0.09789426000000001	3.32047216558697
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.09752158	3.3078312449990723
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.09728178	3.2996974767341327
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.09682066	3.284056762712744
ROBERTS SYNDROME; RBS	0.09672797000000001	3.280912813669887
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09595502900000001	3.254695453467757
TETRASOMY 9P	0.09483284300000001	3.2166320636672583
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.09361180000000001	3.1752155465549694
ROBERTS SYNDROME	0.09350383400000001	3.1715534513735997
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.09325970400000001	3.163272813981941
3P25.3 MICRODELETION SYNDROME	0.09257182000000001	3.1399404993482474
MONOSOMY 13Q34	0.09252355400000002	3.1383033664913857
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.09248751000000001	3.1370807912480934
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.09199607300000001	3.1204117559069036
CHARGE SYNDROME	0.091811704	3.114158149896734
AICARDI SYNDROME	0.09146958999999998	3.102553996451397
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.083542754688195
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09063464000000002	3.0742333550301666
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.0700295739472487
PSEUDOMYXOMA PERITONEI	0.09047619999999999	3.068859233912997
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.09016759400000002	3.058391637210871
MEIER-GORLIN SYNDROME 5; MGORS5	0.08993019	3.050339138790646
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08982882300000002	3.046900874871914
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08979252999999998	3.04566985380586
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.08962860300000002	3.040109619317259
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08928740400000001	3.028536501726646
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08925271000000001	3.0273597170886815
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08881885000000002	3.0126436341052507
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102	3.0079685828960896
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08867000000000001	3.0075947958807454
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.0075947958807454
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.08790998	2.981815702650055
22Q11.2 DELETION SYNDROME	0.08719101300000003	2.9574290847679086
ACROOTOOCULAR SYNDROME	0.08676967000000001	2.9431375654932856
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	2.93230215151399
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.925051260038743
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08622765900000001	2.924753112319607
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.08615821300000001	2.9223975757435974
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.08587826000000001	2.9129018592003337
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.08528754	2.892865247067451
TRICHOHEPATOENTERIC SYNDROME 1	0.0840473	2.850797587547398
WILLIAMS-BEUREN SYNDROME; WBS	0.08388099000000002	2.8451565241606502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.8311637292276015
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	2.8265794451738913
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	2.8265794451738913
ALKAPTONURIA	0.08333330000000001	2.8265794451738913
OROMANDIBULAR DYSTONIA	0.08333330000000001	2.8265794451738913
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	2.8265794451738913
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	2.8265794451738913
SCLEROSTEOSIS	0.08333330000000001	2.8265794451738913
DIPROSOPUS	0.08333330000000001	2.8265794451738913
ERMINE PHENOTYPE	0.08333330000000001	2.8265794451738913
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	2.8265794451738913
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.082877923	2.8111335277794645
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.807465191508183
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.0822917	2.7912494492407744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.08223111	2.7891942990357177
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.08223111	2.7891942990357177
FRIEDREICH ATAXIA	0.08222186000000001	2.7888805485918033
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.7861566520351553
PAPILLARY TUMOR OF THE PINEAL REGION	0.08184921	2.776240645572914
PINEOCYTOMA	0.08184921	2.776240645572914
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.08161245	2.7682099909673794
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.7676520239617153
3MC SYNDROME 2	0.08095217400000002	2.745814111172128
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0807113	2.737643913936727
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.080673794	2.7363717491638124
NORMAL PRESSURE HYDROCEPHALUS	0.0803924	2.7268271553892323
LOCKED-IN SYNDROME	0.08020053	2.7203191232082733
3MC SYNDROME 3	0.07936511000000002	2.691982539872594
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0791926	2.686131178891006
PRIMARY PROGRESSIVE FREEZING GAIT	0.07910191000000001	2.683055067781968
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.07852351	2.663436337321413
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.07785055399999999	2.6406103650257458
N SYNDROME	0.07746865400000001	2.6276567115629423
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.6276567115629423
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.627516456634771
DDOST-CDG	0.07746451900000001	2.627516456634771
NEUROFIBROMATOSIS TYPE 1	0.07746451900000001	2.627516456634771
7Q11.23 MICRODUPLICATION SYNDROME	0.077365189	2.6241472856516324
OKAMOTO SYNDROME	0.076983234	2.611191766645648
DERMATOMYOSITIS	0.07692310000000001	2.6091520834895023
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.6091520834895023
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.6091520834895023
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.6091520834895023
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.6091520834895023
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.6091520834895023
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.6091520834895023
DERMOODONTODYSPLASIA	0.07692310000000001	2.6091520834895023
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.6091520834895023
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07689308	2.6081338361028736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.076616449	2.598750798367684
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.5883258378069627
NOONAN SYNDROME 7; NS7	0.07567976900000001	2.566979580442731
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0754241	2.558307552091901
URBAN-ROGERS-MEYER SYNDROME	0.07502633	2.5448156046242407
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07489701900000001	2.540429509094184
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.07462507	2.5312052799620655
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.07442027300000001	2.5242587772958647
COHEN SYNDROME	0.074356663	2.5221011918107403
MIYOSHI MYOPATHY	0.07404541	2.511543811603204
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07394574999999999	2.5081634473609853
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.07394574999999999	2.5081634473609853
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07394574999999999	2.5081634473609853
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.5025936138047484
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.07356325	2.4951894425180354
MYOPATHY AND DIABETES MELLITUS	0.07356325	2.4951894425180354
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.073394869	2.489478132950818
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.4596533210230103
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.4596533210230103
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.4596533210230103
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.4596533210230103
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.072426573	2.4566345329680486
CRANIOECTODERMAL DYSPLASIA 1	0.07231184	2.4527429081376013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.4412889478777418
RABIES	0.07197001900000001	2.44114869294957
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.44114869294957
VASCULAR EHLERS-DANLOS SYNDROME	0.071945294	2.440310046492728
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.4227843198043013
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.4227843198043013
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.4227843198043013
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.4227843198043013
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.4227843198043013
ESOPHAGEAL ATRESIA	0.07142860000000001	2.4227843198043013
3MC SYNDROME 1	0.07142860000000001	2.4227843198043013
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.07133404	2.4195769422933227
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.07110015	2.411643635122819
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.07038685400000001	2.387449371702017
JACOBSEN SYNDROME	0.070235983	2.382331983245387
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.07019710000000001	2.381013112055039
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.07019710000000001	2.381013112055039
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.07019710000000001	2.381013112055039
2Q23.1 MICRODUPLICATION SYNDROME	0.070081994	2.377108835449933
PHAVER SYNDROME	0.06957387	2.3598737943079224
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.359579513351014
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.356950996929316
SPONDYLO-OCULAR SYNDROME	0.0694118	2.3543765473408715
HOLMES-GANG SYNDROME	0.06909417400000001	2.34360300155722
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.06902777	2.34135064647855
EPISODIC ATAXIA TYPE 1	0.06901964	2.3410748852775742
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.068952349	2.3387924440752554
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.3307716598890913
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.3307716598890913
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06863134	2.327904150426548
YOU-HOOVER-FONG SYNDROME; YHFS	0.06851795399999999	2.3240582144445274
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.068270473	2.315663914594755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.068177764	2.312519321091526
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.068132949	2.310999242589469
TRISOMY 20P	0.06779684	2.2995987725404254
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.298033751407213
KLEEFSTRA SYNDROME	0.06759917300000001	2.2928941121082915
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.289298939048634
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.06734	2.2841032316974106
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.067208119	2.2796299644223956
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.2796299644223956
PEHO SYNDROME	0.06707321399999999	2.2750541261914456
RING CHROMOSOME 10 SYNDROME	0.067056209	2.2744773341591475
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.261265591277127
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	2.261265591277127
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.261265591277127
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.261265591277127
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	2.261265591277127
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.261265591277127
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	2.261265591277127
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.261265591277127
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.261265591277127
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.261265591277127
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.261265591277127
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0666667	2.261265591277127
DESMOID TUMOR	0.0666667	2.261265591277127
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06653733399999999	2.2568776302038898
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.06609733000000001	2.2419531490877667
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.06583433400000001	2.23303259646639
SMITH-MAGENIS SYNDROME; SMS	0.065329293	2.2159021274993616
BECKER MUSCULAR DYSTROPHY	0.06504991	2.2064257447672366
MENTAL RETARDATION, X-LINKED 98; MRX98	0.064903763	2.2014685895102883
CRYPTOCOCCOSIS	0.06486894900000001	2.200287734596295
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.198451056457103
FG SYNDROME TYPE 1	0.064568243	2.1900880977327546
PERLMAN SYNDROME	0.064564384	2.18995720443945
DESMOSTEROLOSIS	0.06439297	2.1841430186455955
ANGELMAN SYNDROME	0.064329413	2.181987230865717
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.06402941000000001	2.1718114390359147
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.06283113	2.131167019367391
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898	2.12227516219202
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.062373160000000004	2.1156331500917678
WILLIAMS SYNDROME	0.06234121	2.1145494390990036
AARSKOG-SCOTT SYNDROME	0.06173154399999999	2.093870198219051
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.061666143	2.0916518638641914
DOORS SYNDROME	0.061520974	2.086727881356881
AMISH INFANTILE EPILEPSY SYNDROME	0.061147400000000005	2.0740566372125664
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109523	2.072287084708889
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.06088125999999999	2.065029443359226
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.060869104	2.064617124397472
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06070200999999999	2.0589494685406664
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.05952815	2.019133350044078
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05949911	2.018148343245021
HYPERTELORISM, TEEBI TYPE	0.058779	1.993722955983696
VELOCARDIOFACIAL SYNDROME	0.058742869999999996	1.9924974637092492
7P22.1 MICRODUPLICATION SYNDROME	0.058454094	1.9827024801209414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.05811118300000001	1.971071293258979
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.9641978520475014
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.057803063999999994	1.9606202150937366
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	1.959767017400091
NORRIE DISEASE	0.05774132900000001	1.9585262276715685
17Q21.31 MICRODUPLICATION SYNDROME	0.057732474	1.958225875219583
CHIME SYNDROME	0.057728339000000004	1.9580856202914116
YUNIS-VARON SYNDROME	0.057407410000000006	1.947200040160057
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.9456139892673605
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.9445540215514332
ALPHA-MANNOSIDOSIS	0.057316824	1.944127456623577
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.05728379000000001	1.9430069774706835
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.05728379000000001	1.9430069774706835
SIMPSON-GOLABI-BEHMEL SYNDROME	0.056942482999999995	1.931430196631643
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.056869403	1.928951398529884
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.056757249	1.9251472507150968
OGDEN SYNDROME	0.056591434	1.9195229772169693
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.9179072811471936
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056485419	1.9159270579400403
MICROHYDRANENCEPHALY; MHAC	0.05646882	1.9153640370083065
MONOSOMY 13Q14	0.05631795	1.910246682470644
ATELOSTEOGENESIS TYPE II	0.0563121	1.9100482565142223
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.056218954	1.9068888404224542
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.05621583	1.9067828775698281
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.9027529311923232
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.05572271	1.8900567566073299
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.055605724	1.8860887123444352
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.8843885580470545
GITELMAN SYNDROME	0.055555600000000004	1.8843885580470545
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.8843885580470545
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.8843885580470545
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.8843885580470545
WILDERVANCK SYNDROME	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.8843885580470545
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8843885580470545
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.8843885580470545
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.8843885580470545
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.8843885580470545
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.055471664	1.881541535640524
PURE MITOCHONDRIAL MYOPATHY	0.05544662	1.8806920690332383
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872624	1.8612227177029534
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05468078	1.8547155674151339
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.054595194	1.8518125787132027
SIFRIM-HITZ-WEISS SYNDROME	0.05458702000000001	1.8515353250776831
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.054524843	1.8494263454721402
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	1.8405421879022579
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.05416457	1.8372062575066916
3Q27.3 MICRODELETION SYNDROME	0.05415799	1.836983070704426
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.054135264	1.8362122282624367
TRICHOTHIODYSTROPHY	0.054080064	1.8343399012890222
HOLOPROSENCEPHALY	0.053892502999999994	1.827978025936477
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.05372105399999999	1.8221626529787804
SLC39A8-CDG	0.05356896900000001	1.8170040868963233
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.053478300000000006	1.81392868808559
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.05344141900000001	1.8126777226669948
MONOSOMY 18P	0.053423134	1.8120575143570505
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.053292754	1.8076351594513675
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05320941900000001	1.80480852234395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.05280410900000001	1.7910608258657905
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.7852094988031693
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.7852094988031693
PENILE AGENESIS	0.0526316	1.7852094988031693
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.05260885900000001	1.7844381475766766
CARDIOFACIOCUTANEOUS SYNDROME	0.052239054	1.7718947440186446
SILVER-RUSSELL SYNDROME; SRS	0.051868253999999996	1.7593175910885377
DIASTROPHIC DWARFISM	0.0518518	1.7587594884070061
20P12.3 MICRODELETION SYNDROME	0.051807133	1.7572444299120515
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.051678879999999996	1.7528942206489853
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0515873	1.7497879216593972
PITT-HOPKINS SYNDROME	0.051423513	1.7442324358261625
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.7360106817610594
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.050919583	1.7271396508313708
LISSENCEPHALY, X-LINKED, 2	0.05083609900000001	1.724307959797884
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.7229381084002695
GIANT AXONAL NEUROPATHY	0.05044494	1.7110402506204627
HISTIDINEMIA	0.05043863	1.710826221939263
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.05029260399999999	1.7058731708773103
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.05025664900000001	1.7046536144220736
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.05	1.6959483454836728
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.049920694	1.693258367893934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704	1.6866784275031264
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.04941234	1.6760155253895337
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.049404979999999994	1.6757658817930787
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.664636186856875
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970853999999994	1.6610407763644495
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.048899293	1.6586135011734269
MEHMO SYNDROME	0.048657729000000004	1.6504198998508586
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.048606510000000006	1.648682604284712
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.04840441	1.641827581072267
DESMINOPATHY	0.04840441	1.641827581072267
OCULOPHARYNGODISTAL MYOPATHY	0.04840441	1.641827581072267
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.048388444	1.6412860308465869
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.04835373900000001	1.6401088730999869
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04835373900000001	1.6401088730999869
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.048330040000000005	1.6393050275031944
XP22.13P22.2 DUPLICATION SYNDROME	0.048286669	1.6378339279893548
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04826488	1.6370948676193602
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6296038637773587
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.048007129	1.628352219979425
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.04774224	1.6193674587536881
ANOPHTHALMIA PLUS SYNDROME	0.047619	1.6151872852717402
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.04761567900000001	1.6150746403826335
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.04757592	1.6137260561772715
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.04753696	1.6124045732264707
ACROCEPHALOPOLYDACTYLY	0.04746115	1.6098331763450484
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.047402563999999994	1.607845999749678
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.047402563999999994	1.607845999749678
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0473363	1.6055983933263753
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.047316830000000004	1.6049379910406443
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.04723343000000001	1.6021091492003776
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04721557	1.6015033564513705
OCULODENTODIGITAL DYSPLASIA; ODDD	0.047146249	1.5991520597462252
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.046918213	1.5914173142080108
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.04685700999999999	1.5893413716762377
DUPLICATION/INVERSION 15Q11	0.046824869	1.5882511821607943
WOLF-HIRSCHHORN SYNDROME	0.04676793299999999	1.5863199718608247
16P13.11 MICRODELETION SYNDROME	0.046763204	1.5861595690663093
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.5855672082281989
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.5842789658649694
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.046659059999999995	1.5826271121764681
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.046376794	1.5730529410627425
JUVENILE PRIMARY LATERAL SCLEROSIS	0.04635260000000001	1.57223230557733
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.046340780000000005	1.5718313833884574
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349	1.5685605434903906
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.5637662671125425
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04601606900000001	1.5608175217242506
FRYNS SYNDROME; FRNS	0.045984359	1.5597419512835446
HUNTINGTON DISEASE	0.045702929999999996	1.5501961703451221
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.045662519	1.5488254709733353
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.045382348999999995	1.539322394014252
MOHR-TRANEBJAERG SYNDROME	0.045358050000000004	1.538498197037314
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.5359644502091616
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.045158184000000004	1.5317189487969454
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.045083864	1.5291980911762184
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.04503282399999999	1.5274668671051481
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5238268870902036
MEHMO SYNDROME; MEHMO	0.044836343	1.520802434567769
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.04465329399999999	1.5145936015939199
DIENCEPHALIC SYNDROME	0.04461426	1.513269608639568
ZELLWEGER SYNDROME	0.044524579	1.5102277217681415
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.50750847210996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.044431554	1.507072409871369
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.044316049999999996	1.5031546335174342
DE BARSY SYNDROME	0.044291424	1.5023193450383168
PGM3-CDG	0.04425729899999999	1.5011618602925239
OCULODENTODIGITAL DYSPLASIA	0.044201799	1.499279357629037
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.4989547531157117
OCULO-PALATO-CEREBRAL SYNDROME	0.044129784	1.496836683227037
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.044081028999999994	1.4951829639953558
COG1-CDG	0.04404964	1.494118281543028
AICARDI-GOUTIERES SYNDROME 6	0.044023854	1.4932436470622952
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.493103392134124
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.493103392134124
6P22 MICRODELETION SYNDROME	0.043959319999999996	1.4910547204517464
NOONAN SYNDROME	0.04385423	1.4874901762192088
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.043850780000000006	1.4873731557833705
HAMAMY SYNDROME; HMMS	0.04363133999999999	1.4799299776847115
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.043589710000000004	1.4785179310922623
SWEENEY-COX SYNDROME; SWCOS	0.043589244000000006	1.4785021248536823
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.043478300000000004	1.4747390189888554
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.4747390189888554
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.4747390189888554
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.043478300000000004	1.4747390189888554
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.043443123	1.4735458514898736
OSGOOD-SCHLATTER DISEASE	0.04338761	1.471662907879817
X-LINKED DYSTONIA-PARKINSONISM	0.04338761	1.471662907879817
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.043303629	1.4688143591197758
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.4676198687810846
PROGRESSIVE SUPRANUCLEAR PALSY	0.04281613	1.4522788966702769
LISSENCEPHALY 2; LIS2	0.042790883999999994	1.451422578431675
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.4502580046217988
ALG13-CDG	0.0426748	1.4474851290769326
WEST SYNDROME	0.0426748	1.4474851290769326
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256881999999999	1.4438903969638452
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.042525433999999994	1.4424187886655022
HUNTINGTON DISEASE-LIKE 3	0.042472318999999994	1.440617182738095
COG2-CDG	0.04221225399999999	1.4317960466087305
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.4316557916805592
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.4316557916805592
SARCOSINEMIA	0.04219884399999999	1.4313411932624718
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.4302003627294324
SHPRINTZEN OMPHALOCELE SYNDROME	0.042057460000000005	1.426545594044915
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904994	1.4213741048360646
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.4132914185352907
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.4132914185352907
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.4132914185352907
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.041589883	1.4106858652541905
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.4100606030181773
MERRF	0.041517359999999996	1.408225960017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.041474173	1.4067611015930723
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.04144528	1.405781080882151
RICHIERI COSTA-DA SILVA SYNDROME	0.04137935	1.4035448033937963
15Q13.3 MICRODELETION SYNDROME	0.041349853	1.4025442956268614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.041266000000000004	1.3997000884945847
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.04122263	1.3982290228997123
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.041205410000000005	1.3976449382895277
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.041188763	1.3970802892473824
MASA SYNDROME	0.041164200000000005	1.3962471376631802
PARKINSONIAN-PYRAMIDAL SYNDROME	0.041164200000000005	1.3962471376631802
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.041079050000000006	1.3933589376308215
TOWNES-BROCKS SYNDROME 2; TBS2	0.041079050000000006	1.3933589376308215
QAZI-MARKOUIZOS SYNDROME	0.041044329	1.3921812371807503
LESCH-NYHAN SYNDROME	0.041030029999999995	1.391696229872909
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.391696229872909
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.040989269999999994	1.3903136927816706
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.3882564735196323
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.040928619000000006	1.3882564735196323
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.040908053	1.3875588960461678
SPINOCEREBELLAR ATAXIA TYPE 11	0.04064041	1.3784807219855622
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.3752633044603781
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.04053880000000001	1.3750342157578703
MAL DE MELEDA	0.04051068	1.3740804144083703
GERODERMA OSTEODYSPLASTICA	0.040484054	1.3731772879954331
SHORT RIB-POLYDACTYLY SYNDROME	0.040389549999999996	1.3699718099466014
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3671043004840577
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.3657997770167118
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040206929	1.36377749429059
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.04018249	1.3629485486582846
9P13 MICRODELETION SYNDROME	0.04012756	1.3610853798059361
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.040113832999999995	1.3606197741471668
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0399385	1.3546726599219934
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03974616	1.3481486858265868
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.039741824	1.3480016131860664
BRACHYDACTYLY TYPE A4	0.0397397	1.3479295693003501
WAISMAN SYNDROME; WSMN	0.039548473	1.341443347015114
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.03940891	1.3367095142362992
CHAR SYNDROME	0.039387604	1.3359868367273218
MONOSOMY 9P	0.039254292999999996	1.3314650653296263
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039177794	1.3288702982800031
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.3269283017485565
DUBOWITZ SYNDROME	0.039098199	1.3261705181088277
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.3257628460455404
OTOFACIOCERVICAL SYNDROME	0.03900606399999999	1.3230453940926046
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.039002919000000004	1.3229387189416741
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.038978482999999994	1.322109875066269
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.038742149999999996	1.3140937038596052
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.038742149999999996	1.3140937038596052
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.03863224	1.3103656702065631
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.309406238308556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.3091091081584274
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.038550633	1.3075976450739655
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3066027000176037
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3045743457964056
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0384615	1.3045743457964056
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0384615	1.3045743457964056
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3045743457964056
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3045743457964056
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.0384615	1.3045743457964056
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3045743457964056
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0384615	1.3045743457964056
CYCLIC NEUTROPENIA	0.0384615	1.3045743457964056
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3045743457964056
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0384615	1.3045743457964056
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3045743457964056
SPASTIC PARAPLEGIA 16, X-LINKED	0.0384615	1.3045743457964056
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3045743457964056
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0384615	1.3045743457964056
BAZEX SYNDROME; BZX	0.0384615	1.3045743457964056
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3045743457964056
LIP, HAMARTOMATOUS	0.0384615	1.3045743457964056
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3045743457964056
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3045743457964056
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3045743457964056
MOSAIC TRISOMY 8	0.038460509999999996	1.3045407660191648
TEMPLE-BARAITSER SYNDROME	0.038439229	1.3038189364843602
BARDET-BIEDL SYNDROME 1; BBS1	0.038309034	1.2994028565875553
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.038263999	1.297875315912778
RETT SYNDROME	0.038210349	1.2960555633380741
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.038207	1.2959419687178935
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.038109669	1.2926406017496082
DISTAL TRISOMY 5Q	0.03808761	1.2918923832585476
BAKER-GORDON SYNDROME; BAGOS	0.038032024	1.2900069635639067
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.03793677399999999	1.28677618196576
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.2849610423705558
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.037708754	1.2790419791310164
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.2747614055070156
JAWAD SYNDROME	0.037582554	1.2747614055070156
ISOTRETINOIN-LIKE SYNDROME	0.03757725	1.2745814993065268
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037521043999999996	1.2726750498524015
FLYNN-AIRD SYNDROME	0.037472419	1.2710257400864189
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.037422679	1.2693386106723317
BRAIN-LUNG-THYROID SYNDROME	0.037381293999999995	1.2679348742267746
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294	1.2588445910949824
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2562567774335758
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A1, D	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A4	0.037037	1.2562567774335758
MYOCLONUS AND ATAXIA	0.037037	1.2562567774335758
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	1.2562567774335758
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.2562567774335758
CANAVAN DISEASE	0.037037	1.2562567774335758
MCLEOD SYNDROME; MCLDS	0.037037	1.2562567774335758
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A3	0.037037	1.2562567774335758
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.2562567774335758
SYNPOLYDACTYLY 1	0.037037	1.2562567774335758
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335758
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2526613669411502
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.036917530000000004	1.252204478456877
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.03683574	1.2494302461533346
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2482611611208592
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.036801273	1.2482611611208592
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.036780129999999994	1.2475440124034878
HAREL-YOON SYNDROME; HAYOS	0.036653203999999995	1.2432388136095105
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388	1.2342433679091975
PITT-HOPKINS SYNDROME	0.036157179	1.2264141580481398
THUMBS, CONGENITAL CLASPED	0.0361093	1.2247901518314714
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.036090284	1.2241451487567172
PHELAN-MCDERMID SYNDROME	0.036045813	1.222636738379277
MICROPHTHALMIA WITH LIMB ANOMALIES	0.036036000000000006	1.2223038915569928
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.035932563	1.2187954153767566
CHROMOSOME 17Q12 DELETION SYNDROME	0.03592785	1.218635555285711
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035920563	1.2183883877738408
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.035884189999999996	1.217154653190435
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.035770528999999995	1.2132993894925144
VESTIBULOPATHY, FAMILIAL	0.035714300000000004	1.2113921599021507
MALARIA	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.035714300000000004	1.2113921599021507
YOUNG-ONSET PARKINSON DISEASE	0.035714300000000004	1.2113921599021507
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.035714300000000004	1.2113921599021507
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA TYPE 1	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.03543121	1.201790039559691
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.1995647518166153
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.03529794	1.197269658839639
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.035256380000000004	1.195859986574873
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.035229109999999994	1.1949350163472459
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.1926434170238616
NEMALINE MYOPATHY 2; NEM2	0.034993869999999996	1.1869559185714145
COSTELLO SYNDROME	0.03496462	1.1859637887893066
MARSHALL-SMITH SYNDROME; MRSHSS	0.03485368	1.1822008186003474
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034617714	1.1741970956545393
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	1.1696209521528877
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	1.1696209521528877
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	1.1696209521528877
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	1.1696209521528877
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	1.1696209521528877
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	1.1696209521528877
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.034446634000000004	1.1683942387956325
SIALIDOSIS TYPE 1	0.034436739	1.1680586106180613
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.1679796133441287
ZUNICH NEUROECTODERMAL SYNDROME	0.034283779	1.1628703654395576
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.1607999856183582
SCHWARTZ-JAMPEL SYNDROME	0.034151310000000004	1.1583771538120002
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.033974330000000004	1.1523741750483263
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03394403	1.151346430350963
FETAL HYDANTOIN SYNDROME	0.033922884	1.150629179876691
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.033878854	1.149135727763658
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.033878854	1.149135727763658
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.033874719000000005	1.1489954728354868
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.033874719000000005	1.1489954728354868
KOOLEN-DE VRIES SYNDROME	0.033874243	1.1489793274072375
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774	1.1474370659008215
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.03379519	1.1462979313161272
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.033624523	1.140509082990554
TRISOMY 12P	0.033553313999999994	1.1380937472758828
H SYNDROME	0.033518240000000005	1.1369040734304934
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.033353173	1.131305171319614
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.1310304276876455
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.0333333	1.1306310996902182
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03326377	1.1282727139209885
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.033249464	1.1277874691803786
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.1245358613365497
PEHO-LIKE SYNDROME; PEHOL	0.033016444	1.1198836715110867
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.033002519	1.1194113498968694
TRISOMY 4P	0.032996029999999996	1.1191912497205925
FRYNS MICROPHTHALMIA SYNDROME	0.032996029999999996	1.1191912497205925
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1169081640579024
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.032920050000000006	1.1166140866147958
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03290601	1.1161378643193838
FOUNTAIN SYNDROME	0.032889259	1.1155696877046797
MUCOLIPIDOSIS TYPE II	0.03284823	1.1141780264113428
CHILDHOOD APRAXIA OF SPEECH	0.0328042	1.1126845742983098
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.112666054542377
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.112666054542377
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.112666054542377
LEIGH SYNDROME	0.032799519	1.1125257996142057
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1125257996142057
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.1125257996142057
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.1125257996142057
SANDHOFF DISEASE	0.032799519	1.1125257996142057
TUBEROUS SCLEROSIS-1	0.032799519	1.1125257996142057
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1125257996142057
MENINGIOMA	0.03270391	1.1092828411069389
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.032655939999999994	1.1076557482642815
PITT-HOPKINS-LIKE SYNDROME	0.032651229000000004	1.1074959560111703
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.032522234	1.1031205788746568
15Q24 MICRODELETION SYNDROME	0.03252194299999999	1.103110708455286
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.032520634	1.1030663085276013
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032337370000000004	1.0968501829758672
ALLAN-HERNDON-DUDLEY SYNDROME	0.032281239999999996	1.094946311363227
DYSTONIA, JUVENILE-ONSET	0.0322581	1.0941614264689372
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.0941614264689372
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.0941614264689372
DENT DISEASE	0.0322581	1.0941614264689372
CONGENITAL ANALBUMINEMIA	0.0322581	1.0941614264689372
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.0941614264689372
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.0941614264689372
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.0941614264689372
MILD CANAVAN DISEASE	0.0322581	1.0941614264689372
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.0941614264689372
SECKEL SYNDROME 2; SCKL2	0.0322581	1.0941614264689372
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.0941614264689372
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.0941614264689372
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.0941614264689372
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.032220603	1.0928895669667251
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.032140369	1.0901681125756946
TONNE-KALSCHEUER SYNDROME; TOKAS	0.031972584	1.0844770187127548
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.031949474	1.0836931513874724
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.0823881530545896
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.03188151	1.0813878827204233
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031858759	1.0806161923042612
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.031762404	1.0773479302476798
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.031525183	1.0693016389984
21Q22.11Q22.12 MICRODELETION SYNDROME	0.031407909	1.0653238260730349
NARP SYNDROME	0.031389972999999995	1.0647154554825429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0646064399228954
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031368354	1.063982161336923
COFFIN-LOWRY SYNDROME	0.031275709	1.060839738647576
11Q22.2Q22.3 MICRODELETION SYNDROME	0.031248272999999997	1.0599091378714423
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.03122715	1.0591926675334093
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.03118225	1.057669705919165
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.030989753000000005	1.0511404065459538
XQ28 (MECP2) DUPLICATION	0.030981663000000003	1.0508660021036544
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.030848553999999997	1.0463510823372746
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.046210827409103
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.030844418999999998	1.046210827409103
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.030824463	1.0455339405054536
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.030677729	1.0405568748149296
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.030567110000000005	1.0368047926143487
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.030498773	1.0344868721726421
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.030447213	1.0327380102387793
RENPENNING SYNDROME 1; RENS1	0.030427489	1.032068992535453
LATHOSTEROLOSIS	0.030361082999999997	1.029816569618849
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.030309789	1.0280767301301845
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.030302999999999997	1.0278464542638346
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 3	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 2	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 1	0.030302999999999997	1.0278464542638346
CARIBBEAN PARKINSONISM	0.030302999999999997	1.0278464542638346
SPINOCEREBELLAR ATAXIA TYPE 26	0.030302999999999997	1.0278464542638346
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.030302999999999997	1.0278464542638346
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.0278464542638346
SPINOCEREBELLAR ATAXIA 18	0.030302999999999997	1.0278464542638346
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.0278464542638346
FREEMAN-SHELDON SYNDROME	0.03028189	1.0271304248723714
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0220035730239745
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.0161224990273736
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.029957354	1.0161224990273736
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254	1.0152032950241217
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.029914163	1.014657504927578
MYOPATHY, DISTAL 3	0.0299107	1.0145400435451697
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.0077655100412013
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.029663389999999998	1.0061515438387383
EAR WAX, WET/DRY	0.0294118	0.9976178709539336
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.9976178709539336
ALKAPTONURIA	0.0294118	0.9976178709539336
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.9976178709539336
OSSIFIED EAR CARTILAGES	0.0294118	0.9976178709539336
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.9976178709539336
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.9976178709539336
EAR FOLDING	0.0294118	0.9976178709539336
EAR MALFORMATION	0.0294118	0.9976178709539336
BLAU SYNDROME	0.0294118	0.9976178709539336
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.9976178709539336
AREDYLD	0.0294118	0.9976178709539336
DARWINIAN POINT OF PINNA	0.0294118	0.9976178709539336
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	0.9976178709539336
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.9976178709539336
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0294118	0.9976178709539336
OSTEOMA OF MIDDLE EAR	0.0294118	0.9976178709539336
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.9976178709539336
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0294118	0.9976178709539336
EAR WITHOUT HELIX	0.0294118	0.9976178709539336
MUSICAL PERFECT PITCH	0.0294118	0.9976178709539336
HAIRY EARS, Y-LINKED	0.0294118	0.9976178709539336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.029353104	0.9956269632722035
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301533	0.9938777282297048
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029202049000000004	0.9905033337256629
ACROCALLOSAL SYNDROME; ACLS	0.029130189	0.9880659167635336
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.029080913000000007	0.9863945257500928
SCHAAF-YANG SYNDROME; SHFYNG	0.028961273000000003	0.9823364605490194
GABRIELE-DE VRIES SYNDROME	0.02882784	0.9778105510373608
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.028827190000000003	0.9777885037088695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02880755	0.9771223351987636
SHUKLA-VERNON SYNDROME; SHUVER	0.028805623000000002	0.9770569733495287
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9708965088224928
DYSTONIA 28, CHILDHOOD-ONSET	0.028539494000000006	0.9680301526048242
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.028535359000000003	0.9678898976766527
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	0.9677031737638148
CHROMOSOME 18Q DELETION SYNDROME	0.028519059	0.9673370185160248
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.028400223000000006	0.9633062241643471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.028400223000000002	0.9633062241643471
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.028360992999999998	0.9619755830924803
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.9613097876910105
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.028340654	0.9612857052245046
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9606989070969673
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9606989070969673
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9606989070969673
MENKES DISEASE	0.028319219000000003	0.9605586521687958
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.028143519999999998	0.9545991236017329
HENNEKAM SYNDROME	0.028131819000000002	0.9542022377699231
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.028063704000000002	0.9518918473388707
CAP MYOPATHY	0.027993940000000005	0.9495255245313843
DISTAL MONOSOMY 7Q36	0.027935149	0.9475313945477974
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9421942790235273
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9421942790235273
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9421942790235273
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9421942790235273
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9421942790235273
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9421942790235273
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9421942790235273
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9421942790235273
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9421942790235273
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9421942790235273
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9421942790235273
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9421942790235273
DWARFISM, LEVI TYPE	0.027777800000000002	0.9421942790235273
CLEFT CHIN	0.027777800000000002	0.9421942790235273
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9421942790235273
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9421942790235273
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9421942790235273
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9421942790235273
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9421942790235273
OROFACIAL CLEFT 3	0.027777800000000002	0.9421942790235273
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9421942790235273
DIMPLES, FACIAL	0.027777800000000002	0.9421942790235273
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9421942790235273
GANGLIOCYTOMA	0.027777800000000002	0.9421942790235273
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9421942790235273
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9421942790235273
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9421942790235273
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.027743873	0.9410435102331827
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.02759332	0.9359369080080308
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9352325467411844
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.027563409000000004	0.9349223577887956
DISTAL MONOSOMY 10Q	0.027543302999999998	0.9342403830401094
BRITTLE CORNEA SYNDROME	0.027257780000000002	0.924555737851159
MUCOPOLYSACCHARIDOSIS TYPE 4	0.027257780000000002	0.924555737851159
CEREBROFACIOTHORACIC DYSPLASIA	0.027245870000000002	0.9241517629552647
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.027197913	0.9225251110591773
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9198993420737989
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9167279186677443
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9167279186677443
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9167279186677443
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354	0.9167060070151207
MELAS	0.02688837	0.9120257322850563
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.026885169	0.9119171576719786
INFANTILE SIALIC ACID STORAGE DISEASE	0.026712733	0.9060683066939421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.026701364	0.9056826819591459
KEPPEN-LUBINSKY SYNDROME	0.026586138999999998	0.9017743689969788
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.026484563000000003	0.898329016014162
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.8967921815424514
SECKEL SYNDROME 1; SCKL1	0.026411979	0.8958670417199901
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.026336443999999997	0.8933049725544678
HURLER SYNDROME	0.026319694	0.8927368298587309
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.026186554000000004	0.8882208586043772
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.02616939	0.8876386734563394
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.026167179	0.887563678620502
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026162674	0.8874108736745739
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.026162440000000002	0.8874029366363173
AL KAISSI SYNDROME; ALKAS	0.026052393	0.8836702560848083
COFS SYNDROME	0.026042469	0.8833336442571966
AYMÉ-GRIPP SYNDROME	0.026041254	0.8832924327124014
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.02601911	0.8825413311091537
CRANIOFACIAL DYSSYNOSTOSIS	0.02601049	0.8822489496143923
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.025913600000000002	0.8789625409105141
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.025818759	0.8757456321698337
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.025776010000000002	0.8742956302534121
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.025641000000000004	0.8697162305309372
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.025641000000000004	0.8697162305309372
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.025641000000000004	0.8697162305309372
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0256073	0.868573161346081
VERVERI-BRADY SYNDROME; VERBRAS	0.02557473	0.8674684205938329
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.025553933	0.8667630078390125
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513389	0.8653877972446267
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0254947	0.8647538856720517
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02544385	0.8630291062046949
19P13.3 MICRODUPLICATION SYNDROME	0.025352614	0.8599344753397239
FRANK-TER HAAR SYNDROME	0.02526559	0.8569827111633765
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8563845162629575
SPINOCEREBELLAR ATAXIA TYPE 40	0.02508944	0.8510078851422376
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.02497197	0.8470234240993582
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8470234240993582
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954454000000004	0.8464292994749686
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.024924	0.8453963312567012
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.024924	0.8453963312567012
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.024878619	0.8438570546193733
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.024875134	0.843738847019693
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.024755060000000002	0.8396660609869809
2P15P16.1 MICRODELETION SYNDROME	0.024740554	0.8391740324529893
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.02467052	0.8367985515244372
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.024621134000000003	0.835123429424636
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.024563314000000003	0.8331622347579188
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02455864	0.8330036975065829
RETT SYNDROME, CONGENITAL VARIANT	0.024555659	0.832902585066225
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.02452519	0.8318691080634542
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0243656	0.8264559801343395
ASPARTYLGLUCOSAMINURIA; AGU	0.024350919000000002	0.8259580157811386
CLASSIC HOMOCYSTINURIA	0.024350919000000002	0.8259580157811386
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0243372	0.8254926814741048
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0242857	0.8237458546782567
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0242857	0.8237458546782567
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.02425478	0.8226970802214095
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228373	0.8218013820622257
TRISOMY 18P	0.024186850000000003	0.8203929647992355
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.024164763000000002	0.8196437965771014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024151954	0.8192093285299554
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.023949163000000002	0.8123308673113758
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.023925473000000003	0.8115273269852858
OCULOCEREBRORENAL SYNDROME OF LOWE	0.023880869000000002	0.8100144053852466
WEAVER SYNDROME	0.023855703000000002	0.8091608006639979
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.8075936426358701
HURLER-SCHEIE SYNDROME	0.0238095	0.8075936426358701
SCIMITAR SYNDROME	0.0238095	0.8075936426358701
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.8075936426358701
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023802843	0.8073678440731523
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.023799364	0.8072498399872736
OHDO SYNDROME	0.023742229	0.8053118798128894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.023667754	0.8027857647522915
CHROMOSOME 10Q26 DELETION SYNDROME	0.023580363	0.7998215523150881
ADAMS-OLIVER SYNDROME	0.023392499	0.7934493995155693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.023326333000000005	0.7912051171510239
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.02325381	0.7887452119138336
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.023242133	0.7883491401372295
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.023207858999999997	0.787186601465367
BARAITSER-WINTER SYNDROME 1; BRWS1	0.023201433	0.7869686381840056
COCKAYNE SYNDROME	0.023084249	0.7829938779656626
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.023059784	0.7821640504402174
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.023053753000000003	0.7819594851507852
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02304886	0.7817935196456962
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022948299000000002	0.7783825944142925
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.022904050000000002	0.7768817140475063
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.022811754	0.773751129077611
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.022808529	0.7736417404093273
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.022744554	0.7714717745012809
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02271952	0.7706226470836642
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.7674902304895559
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.767214130098911
DYSTONIA 12; DYT12	0.02261903	0.767214130098911
BRANCHIOOTORENAL SYNDROME 1	0.02256055	0.7652305489140334
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.02253232	0.7642730164781734
JOUBERT SYNDROME 3; JBTS3	0.02252453	0.764008787725947
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7636246215067279
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7621771635128245
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7621771635128245
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.761703112031295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.761703112031295
MYHRE SYNDROME	0.022435563000000002	0.7609911189968941
GLASS SYNDROME	0.022430953	0.7608347525594404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883	0.7596791333568278
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02231618	0.7569417709703166
RAPID-ONSET DYSTONIA-PARKINSONISM	0.022308269000000002	0.7566734380230942
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.022266243	0.7552479595197482
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0222662	0.755246501004171
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02226572	0.7552302199000543
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.022182923	0.7524218311968341
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02216733	0.7518929327458116
SMITH-MAGENIS SYNDROME	0.022150543	0.751323535048299
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.022134899	0.750792906729964
PEHO SYNDROME; PEHO	0.022063563	0.7483732633064957
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003	0.748048997982839
FRANK-TER HAAR SYNDROME; FTHS	0.02203391	0.747367464180723
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021977984000000002	0.7454705120373326
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7451199934332879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.021958864	0.7448219813900198
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02193308	0.7439474147472206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.743198483957855
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504000000002	0.74192665837461
ASPARTYLGLUCOSAMINURIA	0.021807449	0.7396861410153914
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02177467	0.7385743111990593
MAN1B1-CDG	0.021700113	0.7360454147831748
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.021643443	0.7341232269284035
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.0216279	0.7335960244257265
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0216279	0.7335960244257265
9Q21.13 MICRODELETION SYNDROME	0.021596529	0.7325319525148031
PHOCOMELIA, SCHINZEL TYPE	0.021593479999999998	0.7324285335846954
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02158374	0.7320981628469952
PELGER-HUET ANOMALY; PHA	0.021570044	0.7316336086762004
CARTILAGE-HAIR HYPOPLASIA	0.02156183	0.7313549982820045
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.021432430000000002	0.7269658839638927
MICROPHTHALMIA, SYNDROMIC 1	0.021412859000000003	0.7263020558625034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021386563	0.7254101227086467
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.021324523	0.7233057900015706
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.7231050236364321
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7220128329019405
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021283833	0.7219256272380158
JABERI-ELAHI SYNDROME; JABELS	0.021278913	0.7217587459208202
MYOPATHY, SPHEROID BODY	0.02124328	0.7205501113729279
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353	0.719942046053138
14Q22Q23 MICRODELETION SYNDROME	0.021223324	0.7198732244692784
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.021100294	0.7157001739703812
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7148077659509878
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123	0.7118954495331563
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.020975423000000003	0.7114646786534036
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7114303187399239
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254000000003	0.71101799977817
16P11.2P12.2 MICRODELETION SYNDROME	0.020847004000000002	0.7071088388418302
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7066182349044486
MENTAL RETARDATION, X-LINKED 93	0.02082563	0.7063838548431028
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020822319	0.7062715491436649
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.020795098999999997	0.7053482748643835
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02075321	0.7039274432595042
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7035082048285006
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7035082048285006
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7035082048285006
FETAL TRIMETHADIONE SYNDROME	0.020695374	0.7019657058893163
10Q22.3Q23.3 MICRODELETION SYNDROME	0.020652342999999997	0.7005061388242261
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.020641714000000002	0.7001456141249432
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.020641714	0.7001456141249431
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020598054	0.698664712029667
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.02056768	0.6976344573287526
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.02055111	0.6970724200470593
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.02055111	0.6970724200470593
DISTAL MYOPATHY, WELANDER TYPE	0.02055111	0.6970724200470593
TIBIAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470593
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470593
ADENYLOSUCCINASE DEFICIENCY	0.020519143	0.6959881324318576
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.020510204	0.6956849307866522
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.6953123648541162
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.020402499999999997	0.6920317223746125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020397064	0.6918473388704915
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.02032355	0.6893538199370939
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.02030165	0.6886109945617721
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.020286989999999998	0.6881137425068762
CORNELIA DE LANGE SYNDROME	0.020254649	0.6870167691980505
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.02022581	0.6860385801113424
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.020179114	0.6844547000325284
1P36 DELETION SYNDROME	0.020172442999999998	0.6842284266042737
TURNPENNY-FRY SYNDROME; TPFS	0.020150404	0.6834808864925516
BRADDOCK SYNDROME	0.02014982	0.6834610778158763
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.020135499999999997	0.6829753582097298
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.020122834	0.682545740574852
MOEBIUS SYNDROME; MBS	0.020120930000000002	0.6824811588618559
SPINOCEREBELLAR ATAXIA 40; SCA40	0.01996123	0.6770642998463811
BAND HETEROTOPIA; BH	0.019954873	0.6768486769737363
SOTOS SYNDROME	0.019921083	0.6757025550818583
GABRIELE-DE VRIES SYNDROME; GADEVS	0.019902494000000003	0.6750720354059746
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01987247	0.6740536523434785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003000000002	0.6728506483440931
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6717588307182376
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533	0.6713761908525294
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.019793024	0.6713589260983724
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.019751594	0.6699536632993047
WRINKLY SKIN SYNDROME	0.019749724	0.6698902348311836
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.019749273	0.6698749373771075
MONOSOMY 18Q	0.019738843	0.6695211625522395
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.019735473	0.6694068556337539
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.6690502655346323
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6673882361560585
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.019614843000000003	0.6653152106554401
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6647540891858532
FRIAS SYNDROME	0.019592004	0.66454053537019
KUSKOKWIM SYNDROME	0.01957728	0.6640411125014118
RAINE SYNDROME	0.019573004	0.6638960749989061
AASE-SMITH SYNDROME I	0.01956778	0.6637188823157699
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019518279	0.6620398595347742
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6614204991990036
NANCE-HORAN SYNDROME	0.019444740000000002	0.6595454926272039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183000000003	0.6593909238949965
1Q41Q42 MICRODELETION SYNDROME	0.019423459	0.658823663092399
WARSAW BREAKAGE SYNDROME; WABS	0.019418274	0.6586477932489724
LYMPHEDEMA, HEREDITARY, III	0.019418274	0.6586477932489724
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01941391	0.6584997708773785
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.6583440489002963
HHHH SYNDROME	0.019409319	0.6583440489002963
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.6583440489002963
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01936954	0.6569947863155964
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.019303004000000002	0.6547379539332944
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.019224769	0.652084303557116
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.01921181	0.6516447476649335
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.01921181	0.6516447476649335
KUFOR-RAKEB SYNDROME	0.01921181	0.6516447476649335
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.6514490352258647
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.01920604	0.6514490352258647
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004	0.6512443003415979
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004	0.6512443003415979
BOHRING-OPITZ SYNDROME	0.019180613	0.6505865776542524
DYSTONIA-APHONIA SYNDROME	0.019129043000000002	0.6488373765307207
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.019110134	0.6481960027854257
SALT-AND-PEPPER SYNDROME	0.019082104	0.6472452541429474
RABSON-MENDENHALL SYNDROME	0.019046854	0.6460496105593814
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.01904645	0.6460359072967499
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.01904645	0.6460359072967499
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.01897163	0.6434980901925682
SPINOCEREBELLAR ATAXIA 42	0.01897163	0.6434980901925682
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083	0.6414443985030881
PFEIFFER-PALM-TELLER SYNDROME	0.01887272	0.6401431651755324
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01887272	0.6401431651755324
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.6399796757550278
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.6399796757550278
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.6399796757550278
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.6399796757550278
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.6399796757550278
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.6399796757550278
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.6399796757550278
PUBIC BONE DYSPLASIA	0.0188679	0.6399796757550278
TRACHEOBRONCHOMEGALY	0.0188679	0.6399796757550278
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.6399796757550278
TOE, MISSHAPEN	0.0188679	0.6399796757550278
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.6399796757550278
THROMBOCYTOPENIA 3	0.0188679	0.6399796757550278
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.6399796757550278
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.6399796757550278
KNUCKLE PADS	0.0188679	0.6399796757550278
CARPAL DISPLACEMENT	0.0188679	0.6399796757550278
VESICOURETERAL REFLUX 1	0.0188679	0.6399796757550278
RAYNAUD DISEASE	0.0188679	0.6399796757550278
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.6399796757550278
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.6399796757550278
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.6399796757550278
LETTERER-SIWE DISEASE	0.0188679	0.6399796757550278
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.6399796757550278
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.6399796757550278
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.6399796757550278
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.6399796757550278
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.6399796757550278
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.6399796757550278
SPINAL ARACHNOIDITIS	0.0188679	0.6399796757550278
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.6399796757550278
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.6399796757550278
MONOPHALANGY OF GREAT TOE	0.0188679	0.6399796757550278
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.6399796757550278
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.6399796757550278
NEPHROSIALIDOSIS	0.0188679	0.6399796757550278
VAN DEN BOSCH SYNDROME	0.0188679	0.6399796757550278
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.6399796757550278
48,XXYY SYNDROME	0.018847292999999998	0.6392807076039201
COHEN SYNDROME	0.018836309	0.6389081416713842
SPINOCEREBELLAR ATAXIA TYPE 38	0.018826250000000003	0.63856695078324
FREE SIALIC ACID STORAGE DISEASE	0.018820953	0.6383872820155193
HSD10 DISEASE	0.018820953	0.6383872820155193
MIETENS SYNDROME	0.018639193999999998	0.6322222045089839
MARSHALL-SMITH SYNDROME	0.01863731	0.6321583011753262
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.6295088906700115
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.018543413	0.6289734119394086
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6287406260695074
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0185185	0.6281283887167879
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0185185	0.6281283887167879
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0185185	0.6281283887167879
HYPEREKPLEXIA 4; HKPX4	0.018479873	0.6268182007819678
TRISOMY 17P	0.018479603999999997	0.6268090765798691
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.018467139	0.6263862766573401
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.018427214	0.6250320619034714
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.018415459	0.6246333444474481
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.018400223000000004	0.6241165550676125
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.018400223000000004	0.6241165550676125
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.018400223	0.6241165550676124
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01839085	0.6237986325907681
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018385794	0.6236271382940728
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.018365529	0.6229397704296482
LATHOSTEROLOSIS	0.018353869000000002	0.6225442752754815
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0183277	0.6216566498304221
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0183277	0.6216566498304221
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.018279534	0.6200229088702508
CHOREOACANTHOCYTOSIS	0.018275399	0.6198826539420794
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.018275399	0.6198826539420794
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.01826711	0.619601499625365
CRI-DU-CHAT SYNDROME	0.01826363	0.6194834616205194
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6193584023895234
SMITH-LEMLI-OPITZ SYNDROME	0.018245902999999997	0.6188821800941116
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.018211173	0.6177041743733387
JOUBERT SYNDROME 14	0.018118824	0.6145717916981972
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018115883	0.6144720360165158
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018113994	0.6144079630880236
WIEACKER-WOLFF SYNDROME	0.018075373	0.6130979786670049
ZLOTOGORA-OGUR SYNDROME	0.018032719	0.6116511990524398
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.6110902132587206
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.018008259000000002	0.6108215411218292
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.017984014	0.6099991757691041
COFFIN-SIRIS SYNDROME 7; CSS7	0.017984014	0.6099991757691041
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.01797794	0.6097931519640948
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01797794	0.6097931519640948
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.01797794	0.6097931519640948
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.01794871	0.608801700561325
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.017934049999999997	0.6083044485064291
ANTLEY-BIXLER SYNDROME	0.017934049999999997	0.6083044485064291
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921154	0.607867029509162
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017864729000000003	0.6059531518012838
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.017864729000000003	0.6059531518012838
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.017846503000000003	0.6053349447103882
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017843083000000003	0.6052189418435571
RIN2 SYNDROME	0.01783647	0.6049946357153833
MACS SYNDROME	0.01783647	0.6049946357153833
AL-RAQAD SYNDROME; ARS	0.017824614	0.6045924924437021
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.017784633	0.6032363782276865
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6024117063852116
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.6012344808006777
MOEBIUS SYNDROME	0.01766471	0.5991687139589777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.017662629	0.5990981285888387
PELVIS-SHOULDER DYSPLASIA	0.01763723	0.5982366207482999
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.017582533	0.5963813550152415
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.017578200000000002	0.596234384131622
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017551353000000002	0.595323761626998
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.017529264	0.59457452556693
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017442104	0.591618148411083
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.017395233	0.5900283325130596
MEIER-GORLIN SYNDROME 3; MGORS3	0.01738817	0.5897887628497767
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.017381784	0.5895721563270915
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.5895265692355649
GAPO SYNDROME; GAPOS	0.017305239	0.5869758290049906
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.017301664	0.5868545686982884
CEREBELLAR ATAXIA, CAYMAN TYPE	0.017301664	0.5868545686982884
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.017297529	0.586714313770117
JUVENILE HUNTINGTON DISEASE	0.017297529	0.586714313770117
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314000000002	0.5855537763173024
HYPERPROLINEMIA, TYPE I	0.017254172999999998	0.585243723040781
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.01724419	0.5849051099941218
MOTION SICKNESS	0.0172414	0.5848104760764439
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5848104760764439
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5848104760764439
ALCOHOL DEPENDENCE	0.0172414	0.5848104760764439
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5848104760764439
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5848104760764439
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5848104760764439
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.0172414	0.5848104760764439
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5848104760764439
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5848104760764439
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5848104760764439
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5848104760764439
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5848104760764439
SICKLE CELL ANEMIA	0.0172414	0.5848104760764439
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5848104760764439
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5848104760764439
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5848104760764439
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5848104760764439
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5848104760764439
TRANSSEXUALITY	0.0172414	0.5848104760764439
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5848104760764439
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5848104760764439
PALMOMENTAL REFLEX	0.0172414	0.5848104760764439
DIASTEMATOMYELIA	0.0172414	0.5848104760764439
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5848104760764439
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5848104760764439
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5848104760764439
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5848104760764439
MYOPATHY, CONGENITAL	0.0172414	0.5848104760764439
CERVICAL RIB	0.0172414	0.5848104760764439
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5848104760764439
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5848104760764439
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5848104760764439
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5848104760764439
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5848104760764439
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5848104760764439
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0172414	0.5848104760764439
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0172414	0.5848104760764439
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5848104760764439
CARDIAC ARRHYTHMIA	0.0172414	0.5848104760764439
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5848104760764439
MOSAIC TRISOMY 15	0.0172414	0.5848104760764439
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5848104760764439
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5848104760764439
269800 SENILE PLAQUE FORMATION	0.0172414	0.5848104760764439
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5848104760764439
BARTSOCAS-PAPAS SYNDROME; BPS	0.0172414	0.5848104760764439
ERYTHERMALGIA, PRIMARY	0.0172414	0.5848104760764439
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5848104760764439
RHEUMATOID ARTHRITIS	0.0172414	0.5848104760764439
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5848104760764439
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5848104760764439
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5848104760764439
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.582322994719156
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.01712121	0.5807337554435702
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.01712121	0.5807337554435702
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.01712121	0.5807337554435702
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.01712121	0.5807337554435702
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.580192747921361
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.5800914658861686
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.5777706962512419
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.016991792999999998	0.576344064503021
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.016973164000000002	0.5757121880684608
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.016945979	0.5747901009530212
FACIOCARDIORENAL SYNDROME	0.016899169999999998	0.5732023880309463
NEMALINE MYOPATHY 4	0.016894430000000002	0.5730416121277946
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.016894430000000002	0.5730416121277946
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.016894430000000002	0.5730416121277946
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.016894430000000002	0.5730416121277946
MENTAL RETARDATION, X-LINKED 9	0.016866303	0.5720875733455261
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.016853483000000002	0.5716527321897442
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.016839383000000003	0.5711744747563178
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.016812793	0.5702725694261894
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01675611	0.5683499406248486
UROCANIC ACIDURIA	0.01675611	0.5683499406248486
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.01675611	0.5683499406248486
COFFIN-LOWRY SYNDROME; CLS	0.016739519	0.5677871910448501
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.016732113	0.5675359871759169
DESBUQUOIS DYSPLASIA 1	0.0167202	0.5671319105231221
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5668793498955127
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5668793498955127
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016701364	0.5664930128624114
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016701364	0.5664930128624114
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.565935927749887
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.01668354	0.5658884411962135
MARDEN-WALKER SYNDROME	0.016674553999999998	0.5655836453595631
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.5655836453595631
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.5655836453595631
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.5654433904313916
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.5654433904313916
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.01663864	0.5643654795819691
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.016635843	0.5642706082315228
6Q TERMINAL DELETION SYNDROME	0.016631883000000004	0.5641362891225606
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01662251	0.563818366645716
AU-KLINE SYNDROME; AUKS	0.016598324	0.5629980025120387
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.5629562821827399
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.01655401	0.5614949174124034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.01655401	0.5614949174124034
ZIMMERMANN-LABAND SYNDROME 1	0.016488298999999998	0.5592660681778018
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0163957	0.5561252057609329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016373874	0.5553848903891625
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424	0.5550643561518661
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.5540622541934868
WIEDEMANN-STEINER SYNDROME	0.016332479	0.5539808147539366
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016320749000000002	0.5535829452720862
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.016316853000000003	0.5534507969770062
GAUCHER DISEASE	0.016301509999999998	0.5529303782677109
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5529303782677109
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5526530567942574
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.551194744730943
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.016233654	0.5506287728490881
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.016170554	0.5484884860370877
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.016166419	0.5483482311089163
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.016166419	0.5483482311089163
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.016128999999999998	0.5470790172861231
PENTALOGY OF CANTRELL	0.016128999999999998	0.5470790172861231
ACALVARIA	0.016128999999999998	0.5470790172861231
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.5470790172861231
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.5470790172861231
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.5470790172861231
DIGITOTALAR DYSMORPHISM	0.016128999999999998	0.5470790172861231
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.5470790172861231
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.5470790172861231
TERMINAL TRANSVERSE LIMB DEFECT	0.016128999999999998	0.5470790172861231
MECKEL SYNDROME, TYPE 1; MKS1	0.016128999999999998	0.5470790172861231
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.5470790172861231
MECKEL SYNDROME	0.016128999999999998	0.5470790172861231
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.016128999999999998	0.5470790172861231
GORDON SYNDROME	0.016128999999999998	0.5470790172861231
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.5470790172861231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.016109964	0.5464333358320306
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01609075	0.5457816168018281
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.5441604258594133
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.016031419999999998	0.5437692044950772
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.01603002	0.5437217179414036
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.5426927182422648
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.015846259	0.5374887346631152
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.01576651	0.5347837309710357
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.015733333999999998	0.5336584353248403
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5306072885754476
6Q16 MICRODELETION SYNDROME	0.015642334	0.53057180933606
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.015625	0.5299838579636477
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.015625	0.5299838579636477
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.015625	0.5299838579636477
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.015625	0.5299838579636477
GNE MYOPATHY	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.015625	0.5299838579636477
MYOPATHY, DISTAL, INFANTILE-ONSET	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.015625	0.5299838579636477
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.015625	0.5299838579636477
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.015625	0.5299838579636477
WELANDER DISTAL MYOPATHY; WDM	0.015625	0.5299838579636477
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.015625	0.5299838579636477
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01561356	0.529595824982201
KEIPERT SYNDROME	0.01561158	0.5295286654277199
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.01556441	0.5279287077585906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.01556441	0.5279287077585906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.01556441	0.5279287077585906
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.5273903798347672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015480022999999999	0.525066387897984
RING CHROMOSOME 14 SYNDROME	0.015476224	0.5249375297426941
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5247587767870802
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5247587767870802
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5247587767870802
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.015417573	0.5229481484144749
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.015374479000000002	0.5214864444544695
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5214251868002305
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5211436932938471
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01535388	0.520787747655097
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5204499147446767
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01524879	0.5172232034225595
HENNEKAM-BEEMER SYNDROME	0.015232619	0.5166746998086631
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.015138990000000001	0.5134989008558773
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.5122453575957965
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5117396257991733
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01502789	0.5097305036322126
OROFACIODIGITAL SYNDROME TYPE 2	0.015016924000000001	0.5093585482410812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.015013642999999998	0.5092472601106504
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014959674000000001	0.5074166873855024
ACROCRANIOFACIAL DYSOSTOSIS	0.014949890000000002	0.5070848242132582
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.014938604000000001	0.5067020147527156
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.014928303	0.506352615474579
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01492611	0.5062782311801459
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.50625414871364
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.50625414871364
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.50625414871364
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923059	0.5061747444121046
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.5053179852269332
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.5053179852269332
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.5053179852269332
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.014884783	0.50487646203467
SCARF SYNDROME	0.01488284	0.5048105574819645
LAMB-SHAFFER SYNDROME	0.014875134000000002	0.5045491779229585
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014845379	0.5035399190625612
JOUBERT SYNDROME 2	0.014831254	0.503060813654962
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.503060813654962
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.503060813654962
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.503060813654962
DEXTROCARDIA	0.014831254	0.503060813654962
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.503060813654962
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.503060813654962
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.503060813654962
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.503060813654962
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01480813	0.5022764714641428
SAY-BARBER-MILLER SYNDROME	0.014802593999999999	0.5020886960633307
GAUCHER DISEASE, PERINATAL LETHAL	0.014789139	0.5016323163635612
DISTAL MONOSOMY 10P	0.01476133	0.50068906381277
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688442999999999	0.49821681207162466
X SMALL RINGS	0.014683604	0.4980526781907487
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014682933	0.49802991856395235
SMITH-FINEMAN-MYERS SYNDROME	0.014679989000000001	0.4979300611253703
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.014671019999999998	0.49762584191115733
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.014671019999999998	0.49762584191115733
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.014666644	0.4974774125119607
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652278999999999	0.4969901665523032
3Q29 MICRODELETION SYNDROME	0.014591444	0.4949267062003533
NEONATAL ADRENOLEUKODYSTROPHY	0.014586368999999998	0.49475456744328655
ACRODYSOSTOSIS	0.01457371	0.49432518724117713
KBG SYNDROME	0.014552433	0.4936034933822399
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.4932349977257333
DISTAL ANOCTAMINOPATHY	0.01454149	0.4932323181273474
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.01454149	0.4932323181273474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803	0.49290374509489343
ARGININEMIA	0.014531803	0.49290374509489343
HURLER SYNDROME	0.014527794	0.4927677639565526
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.014525360000000001	0.49268520519109443
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.014523343000000001	0.4926167906348376
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.49106910209371607
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.4901175393960321
AMISH LETHAL MICROCEPHALY	0.01444966	0.4901175393960321
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.4901175393960321
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014426779	0.4893414395141719
6Q25 MICRODELETION SYNDROME	0.014424493000000002	0.4892639007558164
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.01441446	0.48892359176081157
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.014408900000000002	0.4887350023047939
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014386884	0.4879882423293105
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0143777	0.48767673053721206
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.014366723000000001	0.48730440203744463
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.014346413	0.4866155078195091
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.48541803261172994
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.4845561855815221
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.4845561855815221
INFANT BOTULISM	0.0142857	0.4845561855815221
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.4845561855815221
WILSON DISEASE	0.0142857	0.4845561855815221
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.4845561855815221
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.4845561855815221
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.4845561855815221
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.4845561855815221
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.4845561855815221
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.4845561855815221
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.4845561855815221
HYPOPHOSPHATASIA, ADULT	0.0142857	0.4845561855815221
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.4845561855815221
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.4845561855815221
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.48395968662944855
KABUKI SYNDROME	0.014263029	0.48378720868271285
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.48365699376874655
MENTAL RETARDATION, X-LINKED 45	0.014257039999999999	0.48358406798989073
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.4831469881822927
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.014222634	0.4824170520143966
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01418537	0.4811530956314745
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0141756	0.48082170732476703
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.014127204	0.4791801650022065
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.014109179999999999	0.4785688095426265
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01407476	0.4774013187015955
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.47675244886461343
CHST3-RELATED SKELETAL DYSPLASIA	0.014017499999999999	0.47545911865634755
FONTAINE PROGEROID SYNDROME; FPS	0.014015060000000001	0.4753763563770881
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.014007094000000001	0.47510615788668564
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.014007094000000001	0.47510615788668564
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699	0.4745161374572918
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249	0.4743991170214534
ANGELMAN SYNDROME	0.013986249	0.4743991170214534
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249	0.4743991170214534
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.01398084	0.474215649329439
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01398084	0.474215649329439
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.013964279000000001	0.47365391731844797
CARNOSINASE DEFICIENCY	0.013932159999999999	0.472564474020276
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.013916929000000001	0.4720478542352749
SPINOCEREBELLAR ATAXIA TYPE 21	0.013900140000000002	0.4714783886998284
GM1 GANGLIOSIDOSIS	0.013834389	0.46924818270655044
LISSENCEPHALY 8; LIS8	0.013789673	0.46773146218221745
NATIVE AMERICAN MYOPATHY	0.013757239999999999	0.466631368328436
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.4665682790499841
MEIER-GORLIN SYNDROME 6; MGORS6	0.01375064	0.4664075031468322
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.46464236010885274
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.46464236010885274
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.46464236010885274
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.46464236010885274
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.46464236010885274
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.463712098522388
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819000000001	0.46336086762003836
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.4622677949924073
HALL-RIGGS SYNDROME	0.013593969	0.4610933846821267
MENKES DISEASE	0.013586849	0.46085188163772983
MOSAIC TRISOMY 14	0.013579093	0.4605888061303784
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.013536794	0.45915406774906614
SPINOCEREBELLAR ATAXIA TYPE 13	0.013494233	0.45771044259842353
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013475493	0.4570748011585362
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.4568312629761248
SYRINGOMYELIA, ISOLATED	0.013461540000000001	0.4566015298132456
SPINOCEREBELLAR ATAXIA TYPE 8	0.013461540000000001	0.4566015298132456
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.013461540000000001	0.4566015298132456
CHIARI MALFORMATION TYPE I	0.013461540000000001	0.4566015298132456
SPINOCEREBELLAR ATAXIA TYPE 43	0.013461540000000001	0.4566015298132456
SPINOCEREBELLAR ATAXIA TYPE 6	0.013461540000000001	0.4566015298132456
TRISOMY 9P	0.013448494	0.45615902297094196
OROFACIODIGITAL SYNDROME TYPE 6	0.013424083	0.4553310270697099
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.013413308999999998	0.4549655841202251
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.013340999999999999	0.4525129375419535
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.013340999999999999	0.4525129375419535
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.4513658998379691
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.4513658998379691
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.4505141945788672
SECKEL SYNDROME 7; SCKL7	0.013267979	0.45003614065924225
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.013263409	0.44988113098046506
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.01325944	0.4497465066008006
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.01325944	0.4497465066008006
KRABBE DISEASE	0.013253094	0.44953125683679174
GERMAN SYNDROME	0.013243814	0.44921648882387005
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.013230179999999998	0.44875403762902344
KLEEFSTRA SYNDROME	0.013229809	0.4487414536923
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.013167282999999998	0.44662063636730576
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.013122213999999998	0.44509194244765365
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013111733	0.44473643775547345
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.44269722946486384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.44269722946486384
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.013029019999999999	0.4419308982454736
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01299215	0.440680305935514
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01299124	0.4406494396756261
PFEIFFER SYNDROME	0.01294239	0.4389924981420886
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012909309	0.4378704247977497
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.4372841015357491
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.012863633999999999	0.4363211759841504
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.43568550062529615
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.43563723393538367
MONOSOMY 5P	0.012808420000000001	0.43444837414519966
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.43367943116535734
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.4328612717645291
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.4328612717645291
FAMILIAL DYSAUTONOMIA	0.012761629	0.4328612717645291
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.4328612717645291
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.4328612717645291
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.43214982143359876
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.43214982143359876
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.43214982143359876
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.43200956650542727
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.43200956650542727
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.43200956650542727
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.43200956650542727
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.012714873	0.43127535654770044
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.012714873	0.43127535654770044
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.012714393	0.4312590754435837
GAUCHER DISEASE TYPE 3	0.01270754	0.4310266287633518
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.012690229	0.4304394575271785
KNIEST-LIKE DYSPLASIA, LETHAL	0.012688389999999999	0.4303770805470315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.012621728999999998	0.42811600829386576
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.4276981605405056
JOHNSON NEUROECTODERMAL SYNDROME	0.01258868	0.42699502035646797
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.42674378256856804
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01257666	0.4265873143742137
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012570314	0.426372064610205
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603000000001	0.42607659648945484
MONOSOMY 22Q13.3	0.012540663	0.4253663333223663
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.012513914000000001	0.4244590348764994
DUCHENNE MUSCULAR DYSTROPHY	0.012513874	0.424457678117823
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.4243328563195954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.4241926013914239
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01247786	0.423236120443538
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.012459853000000002	0.4226253416063956
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012453503	0.42240995616651905
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.01244335	0.42206557689548513
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.4198099655959919
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.41899896309718154
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.41891972839048064
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01233253	0.41830667698255514
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.4179844128779463
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.012318079999999999	0.4178165479107103
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.012318079999999999	0.4178165479107103
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.012318079999999999	0.4178165479107103
GENITOPATELLAR SYNDROME; GTPTS	0.012310813999999998	0.41757009269714457
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.41587041326530094
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.41449689861926065
NEUROFERRITINOPATHY	0.01222021	0.41449689861926065
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.41449689861926065
CORTICOBASAL SYNDROME	0.01222021	0.41449689861926065
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.41449689861926065
RHEUMATIC FEVER	0.01222021	0.41449689861926065
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.41449689861926065
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.41449689861926065
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.012196592999999999	0.41369583437775487
RAMOS-ARROYO SYNDROME	0.0121951	0.41364519336015876
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.41364519336015876
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.41364519336015876
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.41364519336015876
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.41364519336015876
JOUBERT SYNDROME 4	0.0121951	0.41364519336015876
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.41364519336015876
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.41364519336015876
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.41364519336015876
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012176874	0.41302698626926304
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.012173454	0.412910983402432
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.012173454	0.412910983402432
MENTAL RETARDATION, X-LINKED 102	0.012169319	0.4127707284742604
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.012169319	0.4127707284742604
CEREBROFACIOARTICULAR SYNDROME	0.012163364000000001	0.41256874102631336
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.012110869	0.41078816485839
MELNICK-NEEDLES SYNDROME	0.012088149999999999	0.4100175598491691
BARTH SYNDROME; BTHS	0.012088149999999999	0.4100175598491691
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024000000001	0.4096740963902419
CHROMOSOME 9P DELETION SYNDROME	0.012078024000000001	0.4096740963902419
FUMARASE DEFICIENCY; FMRD	0.012039854	0.40837940942329953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.40837940942329953
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.40837940942329953
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.40837940942329953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.40837940942329953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.40837940942329953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.40837940942329953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.40837940942329953
PALLISTER-KILLIAN SYNDROME	0.011995109	0.40686170524892623
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01196832	0.4059530500443829
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.01196832	0.4059530500443829
NEMALINE MYOPATHY 3; NEM3	0.01196832	0.4059530500443829
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01196832	0.4059530500443829
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.01196832	0.4059530500443829
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01196832	0.4059530500443829
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.40534284782967794
COCKAYNE SYNDROME A; CSA	0.011926209	0.4045246884288497
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01192077	0.40434020316782804
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01192077	0.40434020316782804
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.011918434000000002	0.404260968461127
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.4009423028197177
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.39933623973654453
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.3988164994065877
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.3988164994065877
MOSAIC TRISOMY 1	0.011706200000000002	0.3970622104380195
8P23.1 MICRODELETION SYNDROME	0.011696313	0.3967268536121834
CEDNIK SYNDROME	0.011684583	0.396328984130333
AYME-GRIPP SYNDROME; AYGRP	0.011679439	0.3961545049645496
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.39594898994404387
SNEDDON SYNDROME	0.011666289	0.3957084705496874
PSEUDOACHONDROPLASIA	0.01166456	0.3956498246559005
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.01166456	0.3956498246559005
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3956292358429864
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.011649879	0.39515186030269966
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.011647403	0.3950678769406313
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0116279	0.39440635532899193
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0116279	0.39440635532899193
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.0116279	0.39440635532899193
VAN MALDERGEM SYNDROME 2; VMLDS2	0.011617810000000001	0.3940641129528734
VAN MALDERGEM SYNDROME 1; VMLDS1	0.011617810000000001	0.3940641129528734
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.39403697777934565
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.39403697777934565
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.011603549999999999	0.39358042848474134
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.011567753	0.3923662312262758
SHPRINTZEN-GOLDBERG SYNDROME	0.01154303	0.3915276526073679
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.3905358620149292
PMM2-CDG	0.011510853	0.39043624200911536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.39019270382670396
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.39019270382670396
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.39019270382670396
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.39019270382670396
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.39019270382670396
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.39019270382670396
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.39019270382670396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.38987478134985953
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.38987478134985953
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.38987478134985953
RING CHROMOSOME 22 SYNDROME	0.011430733	0.38771865438031233
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01142043	0.387369187264242
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011385199	0.3861741881410473
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.3855455000893765
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.38265716438115016
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.3793756400085069
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.3793756400085069
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.011183854	0.3793447737486191
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.011179719	0.3792045188204476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011179719	0.3792045188204476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.011179719	0.3792045188204476
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.37734409740441893
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.37605867031544304
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.37605867031544304
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.37557328989896555
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.011051623	0.3748596348351861
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0110272	0.37403123190635107
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.37270578043642183
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.010959549999999998	0.37173661379491163
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.37168807575326396
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.37168807575326396
XYLOSIDASE DEFICIENCY	0.010958119	0.37168807575326396
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.37168807575326396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.37168807575326396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.37168807575326396
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.37168807575326396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.37168807575326396
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.37168807575326396
FETAL ALCOHOL SYNDROME	0.010948804000000001	0.3713721205765004
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01086549	0.36854619576738784
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.010847729	0.3679437609961051
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.010839473	0.36766372600529884
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.367292652507307
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.36617943201333153
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.36617943201333153
RECOMBINANT 8 SYNDROME	0.010795713	0.36617943201333153
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010783629999999999	0.36576958913616187
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010756224	0.3648400059290354
PROTEUS SYNDROME	0.010733620000000001	0.3640733016010092
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01070843	0.3632188828245545
DYSTONIA 16	0.01068627	0.36246723851783613
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.36246723851783613
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010686223000000002	0.36246564432639145
%608572 BURN-MCKEOWN SYNDROME	0.01067281	0.3620106892232319
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.01067281	0.3620106892232319
WOODHOUSE-SAKATI SYNDROME	0.01067281	0.3620106892232319
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010654803000000001	0.3613999103860895
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.3608710119350669
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3608710119350669
AASE-SMITH SYNDROME	0.01063921	0.3608710119350669
HYDROLETHALUS SYNDROME 1	0.01063921	0.3608710119350669
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0106383	0.3608401456751791
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0106383	0.3608401456751791
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA-NEUROPATHY-POIKILODERMA SYNDROME	0.0106383	0.3608401456751791
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0106383	0.3608401456751791
PRIMARY LATERAL SCLEROSIS, ADULT	0.0106383	0.3608401456751791
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0106383	0.3608401456751791
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0106383	0.3608401456751791
EPISODIC ATAXIA, TYPE 1; EA1	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.0106383	0.3608401456751791
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.0106383	0.3608401456751791
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.3608401456751791
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0106383	0.3608401456751791
SPASTIC PARAPLEGIA TYPE 2	0.0106383	0.3608401456751791
PRIMARY LATERAL SCLEROSIS	0.0106383	0.3608401456751791
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.3608273921436211
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01059269	0.3592931015944289
MONOSOMY 22	0.01055989	0.3581805594797916
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.35769429717017454
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.35769429717017454
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.35769429717017454
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.35769429717017454
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3572089167536971
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.01052012	0.3568316021657939
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.3558279399349366
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.3558279399349366
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.3533237026079955
DEAFNESS-HYPOGONADISM SYNDROME	0.010403250000000001	0.3528674925030604
MILROY DISEASE	0.010403250000000001	0.3528674925030604
HUNTINGTON DISEASE-LIKE 1	0.010342529	0.3508078989133381
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010332818999999998	0.3504785457446451
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114000000002	0.3489282793620386
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.34806402408518
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010260353	0.3480205738885688
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.347815058868063
STURGE-WEBER SYNDROME	0.010250159	0.34767480393989153
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.34767480393989153
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010220064000000001	0.34665401263074497
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.01018385	0.345425671163078
RIGID SPINE SYNDROME	0.010160934	0.3446483841173759
ZEBRA BODY MYOPATHY	0.010160934	0.3446483841173759
HYPOPHOSPHATASIA, CHILDHOOD	0.010156799	0.34450812918920437
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149532999999999	0.34426167397563867
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010138204	0.343877405999519
ABLEPHARON MACROSTOMIA SYNDROME	0.010138204	0.343877405999519
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010134068999999999	0.3437371510713475
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.3428952823126495
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010109249	0.3428952823126495
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.3423227640701811
FILIPPI SYNDROME	0.010064993	0.34139416451309496
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.01005432	0.341032147379268
SPINOCEREBELLAR ATAXIA TYPE 35	0.01005432	0.341032147379268
SPINOCEREBELLAR ATAXIA TYPE 27	0.01005432	0.341032147379268
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.01005432	0.341032147379268
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033372999999998	0.340321646779411
TRISOMY 8Q	0.010023853999999999	0.33999877213339785
WOLCOTT-RALLISON SYNDROME	0.010023138999999999	0.3399745200720574
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.3397168715994116
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.3397168715994116
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.3397168715994116
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.3397168715994116
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.33918966909673454
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.33918966909673454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.33918966909673454
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.33918966909673454
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.33918966909673454
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.33918966909673454
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.33918966909673454
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009998008999999999	0.3391221364336173
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.3391221364336173
KEIPERT SYNDROME; KPTS	0.00998569	0.3387042886802571
PELVISCAPULAR DYSPLASIA	0.00998569	0.3387042886802571
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009975803	0.33836893185442113
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.009948163000000001	0.33743141160903783
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00991864	0.3364300219489635
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00991864	0.3364300219489635
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.33625462697107356
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.33625462697107356
FRYNS SYNDROME	0.009913469	0.33625462697107356
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.3358367792177133
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.3358367792177133
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.3358367792177133
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.3358367792177133
BARBER-SAY SYNDROME	0.009901150000000001	0.3358367792177133
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009891263	0.3355014223918774
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.3344038046226803
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.3344038046226803
INFANTILE REFSUM DISEASE	0.009858903	0.3344038046226803
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.3344038046226803
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.332569161621503
BIOTINIDASE DEFICIENCY	0.009804814	0.332569161621503
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.332569161621503
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.332569161621503
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3324289066933315
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3324289066933315
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.009799413	0.3323859652812238
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.009795044000000001	0.33223777331479554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.009790909	0.33209751838662405
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.009790909	0.33209751838662405
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009788573	0.332018283679923
2Q24 MICRODELETION SYNDROME	0.009753879	0.3308414990419588
LOWRY-MACLEAN SYNDROME	0.009753879	0.3308414990419588
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743583	0.3304922693586568
JOUBERT SYNDROME	0.009743583	0.3304922693586568
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743583	0.3304922693586568
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.3304236512885986
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.3304236512885986
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009718934	0.32965620074330027
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.32955939601174
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.32955939601174
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.329310430794623
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.329310430794623
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.329310430794623
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.329310430794623
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.329310430794623
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.329310430794623
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.329310430794623
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.329310430794623
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.329310430794623
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.329310430794623
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.329310430794623
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.329310430794623
ENAMEL-RENAL SYNDROME	0.00970874	0.329310430794623
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.329310430794623
OTODENTAL SYNDROME	0.00970874	0.329310430794623
HYPOPLASMINOGENEMIA	0.00970874	0.329310430794623
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.329310430794623
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00967451	0.32814938455730497
TREACHER-COLLINS SYNDROME	0.009634394000000001	0.3267886912807565
17Q24.2 MICRODELETION SYNDROME	0.009630259	0.32664843635258495
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00961538	0.3261437560439359
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00961538	0.3261437560439359
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00961538	0.3261437560439359
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.00961538	0.3261437560439359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00961538	0.3261437560439359
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00961538	0.3261437560439359
CAMURATI-ENGELMANN DISEASE	0.00961538	0.3261437560439359
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00961538	0.3261437560439359
TYPICAL NEMALINE MYOPATHY	0.00961538	0.3261437560439359
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00961538	0.3261437560439359
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.00961538	0.3261437560439359
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00961538	0.3261437560439359
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00961538	0.3261437560439359
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00961538	0.3261437560439359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00961538	0.3261437560439359
CZECH DYSPLASIA, METATARSAL TYPE	0.00961538	0.3261437560439359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00961538	0.3261437560439359
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00961538	0.3261437560439359
CAMURATI-ENGELMANN DISEASE	0.00961538	0.3261437560439359
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00961538	0.3261437560439359
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00961538	0.3261437560439359
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00961538	0.3261437560439359
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.32453090916738103
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00954235	0.32366665389052246
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009530794	0.3232746863089143
OGDEN SYNDROME; OGDNS	0.009530794	0.3232746863089143
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.32302979136782645
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.32161387801314906
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.3213524984541431
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.3213524984541431
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.3212122435259716
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.3212122435259716
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.3212122435259716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.3212122435259716
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009454179	0.32067598465912966
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009442269	0.32027200976323544
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.3195269457360976
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.3195269457360976
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.3195269457360976
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.3195269457360976
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.3195269457360976
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.3195269457360976
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.3186751387200949
W SYNDROME	0.009392853999999999	0.3185959040133939
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.009349844	0.31713704924660885
FORSYTHE-WAKELING SYNDROME; FWS	0.009338114	0.3167391797647584
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00933297	0.316564700598975
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00933297	0.316564700598975
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.316434790955711
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.31603943147741187
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.31603943147741187
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.31603943147741187
2Q33.1 DELETION SYNDROME	0.009313349	0.3158991765492404
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3158991765492404
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.3158991765492404
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.3158991765492404
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.3158991765492404
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.3158991765492404
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3158991765492404
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3158991765492404
PINEOBLASTOMA	0.009313349	0.3158991765492404
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3158991765492404
SCLERODERMA	0.009313349	0.3158991765492404
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00930341	0.31556205593712505
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.009301074	0.3154828212304241
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.314064533548063
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.314064533548063
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.314064533548063
GAUCHER DISEASE TYPE 2	0.00925926	0.314064533548063
PAINE SYNDROME	0.00925926	0.314064533548063
CARNOSINEMIA	0.00925926	0.314064533548063
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.314064533548063
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.314064533548063
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.314064533548063
HYDROXYLYSINURIA	0.00925926	0.314064533548063
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.314064533548063
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00923417	0.31321350666829934
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00922215	0.3128058006860451
1Q44 MICRODELETION SYNDROME	0.009219124	0.3127031618921764
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.31233103690621034
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.3119876412852168
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009190254	0.3117239213174941
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.009108822999999999	0.30896186592307245
NON-DISTAL MONOSOMY 10Q	0.00909342	0.30843941207576275
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00908884	0.3082840632073165
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00908884	0.3082840632073165
DUBOWITZ SYNDROME	0.00906044	0.3073207645470817
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00904871	0.3069228950652313
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00904871	0.3069228950652313
MCDONOUGH SYNDROME	0.00904871	0.3069228950652313
CHARGE-LIKE SYNDROME, X-LINKED	0.00904871	0.3069228950652313
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00904871	0.3069228950652313
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.30658438377547276
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.009037564	0.306544834260056
CARPENTER SYNDROME	0.00902538	0.3061315655672286
DESANTO-SHINAWI SYNDROME	0.009023483	0.306067221287001
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009005223	0.3054478609512303
GENITOPATELLAR SYNDROME	0.008998003000000001	0.30520296601014246
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.3028478703807031
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.3028478703807031
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.30116257259082907
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.30116257259082907
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.30116257259082907
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.30116257259082907
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.30116257259082907
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.3010223176626576
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.3010223176626576
INCONTINENTIA PIGMENTI	0.008808752999999999	0.29878380152248674
600736 VELOFACIOSKELETAL SYNDROME	0.00880429	0.29863242117316885
DERMOTRICHIC SYNDROME	0.008798549	0.2984376923841404
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008798549	0.2984376923841404
NIJMEGEN BREAKAGE SYNDROME	0.00879256	0.2982345516913184
NANCE-HORAN SYNDROME	0.00879256	0.2982345516913184
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00879256	0.2982345516913184
BREATH-HOLDING SPELLS	0.00877193	0.29753480340397187
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.29753480340397187
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.29753480340397187
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.29753480340397187
HISTIDINEMIA	0.00877193	0.29753480340397187
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.29753480340397187
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.29753480340397187
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.29753480340397187
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.29753480340397187
CAFFEY DISEASE	0.00877193	0.29753480340397187
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.29753480340397187
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.29753480340397187
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008759063	0.29709836805674505
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00875552	0.2969781931569841
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00875552	0.2969781931569841
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008712734	0.2955269362387868
SECKEL SYNDROME 9; SCKL9	0.008712734	0.2955269362387868
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.008708599	0.2953866813106153
ALEXANDER DISEASE	0.008662599	0.29382640883277034
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.29382640883277034
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.29382640883277034
CADASIL	0.008662599	0.29382640883277034
PARTINGTON SYNDROME	0.008662599	0.29382640883277034
WEAVER SYNDROME	0.008637533999999999	0.2929762299271793
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.2914005582383574
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588743999999999	0.29132132353165635
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584609	0.2911810686034849
RUBINSTEIN-TAYBI SYNDROME	0.008537163	0.2895717492994886
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.2881206958950927
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.2881206958950927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.2881206958950927
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.2881206958950927
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.28770284814173247
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.28770284814173247
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.28770284814173247
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.287562593213561
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.287562593213561
LATERAL MENINGOCELE SYNDROME	0.00843149	0.2859874303092426
COFFIN-SIRIS SYNDROME 6; CSS6	0.008384044	0.28437811100524624
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.008376464	0.2841210052360709
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.2830362427553326
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.008336109999999999	0.28275223924539794
SYDENHAM CHOREA	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.28265794451738907
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.28265794451738907
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.28265794451738907
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.28265794451738907
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.28265794451738907
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.28265794451738907
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.28265794451738907
KURU, SUSCEPTIBILITY TO	0.00833333	0.28265794451738907
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.28265794451738907
PLAGUE	0.00833333	0.28265794451738907
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.28265794451738907
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.28265794451738907
NOONAN SYNDROME 6; NS6	0.008299504000000001	0.2815106015427025
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00826886	0.2804711887207224
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.008267163000000001	0.2804136282338767
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008267163000000001	0.2804136282338767
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.008267163000000001	0.2804136282338767
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.28027917344904674
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259943	0.2801687332927889
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259943	0.2801687332927889
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259943	0.2801687332927889
LATERAL MENINGOCELE SYNDROME	0.008255424	0.2800154534813241
CAREY-FINEMAN-ZITER SYNDROME	0.00818825	0.27773698079813364
DISTAL TRISOMY 17Q	0.008182773	0.2775512066163694
AMYLOIDOSIS	0.00816718	0.27702230816534684
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00816718	0.27702230816534684
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008131213	0.27580234468250664
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.27568420492076023
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.2754620356875019
MUCOLIPIDOSIS TYPE IV	0.00812118	0.2754620356875019
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.2751782356913686
19P13.13 MICRODELETION SYNDROME	0.008107573	0.2750005003047619
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008059213999999999	0.273360212983977
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.008037443	0.2726217631553865
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.008022569	0.27211725244157203
FEMORAL-FACIAL SYNDROME	0.00802185	0.272092864704364
MEIER-GORLIN SYNDROME 1; MGORS1	0.00802185	0.272092864704364
POTOCKI-SHAFFER SYNDROME	0.007991609	0.2710671212260486
OROFACIODIGITAL SYNDROME TYPE 1	0.007991609	0.2710671212260486
OROFACIODIGITAL SYNDROME I; OFD1	0.007991609	0.2710671212260486
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.007983523000000001	0.27079285245961693
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.007983523000000001	0.27079285245961693
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007983523000000001	0.27079285245961693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007983523000000001	0.27079285245961693
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007983523000000001	0.27079285245961693
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007983523000000001	0.27079285245961693
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007983523000000001	0.27079285245961693
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007983523000000001	0.27079285245961693
SALLA DISEASE	0.007983523000000001	0.27079285245961693
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.007970539	0.27035244859326174
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2697563227498242
300270 ADRENOMYODYSTROPHY	0.007952964	0.2697563227498242
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2697563227498242
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.2696160678216527
BOWEN-CONRADI SYNDROME	0.007948829	0.2696160678216527
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.2696160678216527
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.2696160678216527
ADRENOMYODYSTROPHY	0.007948829	0.2696160678216527
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2696160678216527
COG8-CDG	0.007948829	0.2696160678216527
DPM1-CDG	0.007948829	0.2696160678216527
CROME SYNDROME	0.007948829	0.2696160678216527
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.2696160678216527
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.2696160678216527
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2696160678216527
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.2696160678216527
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2696160678216527
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.2696160678216527
4Q21 MICRODELETION SYNDROME	0.007948829	0.2696160678216527
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2696160678216527
LISSENCEPHALY 5; LIS5	0.007948829	0.2696160678216527
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2696160678216527
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2691982200682925
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2691982200682925
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2691982200682925
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2691982200682925
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2691982200682925
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2691982200682925
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.2691982200682925
184705 STEINFELD SYNDROME	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.2691982200682925
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2691982200682925
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2691982200682925
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2691982200682925
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2691982200682925
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2691982200682925
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2691982200682925
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.2691982200682925
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.2691982200682925
WOLFRAM-LIKE SYNDROME	0.00793651	0.2691982200682925
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.2691982200682925
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2691982200682925
KENNERKNECHT SYNDROME	0.00793651	0.2691982200682925
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.2691982200682925
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2691982200682925
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.2691982200682925
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.2691982200682925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.007926623	0.2688628632424565
POTOCKI-SHAFFER SYNDROME	0.007926623	0.2688628632424565
CK SYNDROME	0.007926623	0.2688628632424565
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.007909748999999999	0.2682905145948226
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00786946	0.26692395333699886
OMODYSPLASIA 1; OMOD1	0.00786946	0.26692395333699886
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00786946	0.26692395333699886
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00786946	0.26692395333699886
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00785773	0.26652608385514837
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00785773	0.26652608385514837
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00785773	0.26652608385514837
LEPRECHAUNISM	0.00785773	0.26652608385514837
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00783091	0.2656163771626309
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00783091	0.2656163771626309
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.007829344	0.2655632600604504
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.007824604	0.26540248415729856
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007824604	0.26540248415729856
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007815084	0.26507957559231843
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.007815084	0.26507957559231843
DUANE RETRACTION SYNDROME	0.007803493	0.26468642084686844
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.2619148003037783
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.2619148003037783
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.2619148003037783
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.2619148003037783
SCARF SYNDROME	0.00770987	0.26151082540788406
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0076720899999999995	0.26022936683803655
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.007669754	0.2601501321313356
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.007669754	0.2601501321313356
TOLUENE EMBRYOPATHY	0.0076413539999999995	0.2591868334711009
FIBULAR HEMIMELIA	0.00762881	0.25876135395018596
CHARLIE M SYNDROME	0.00759805	0.2577180065280444
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2573704727930879
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2573704727930879
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2573704727930879
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2573704727930879
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2573704727930879
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.25723021786491634
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.25723021786491634
FRIED SYNDROME	0.007578064000000001	0.2570401020553877
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.2566736076179286
THAUVIN-ROBINET-FAIVRE SYNDROME	0.007566154	0.25663612715949347
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.007566154	0.25663612715949347
POTOCKI-LUPSKI SYNDROME	0.007564923	0.25659437291122766
HYPERTRICHOSIS CUBITI	0.007558934	0.2563912322184056
DISTAL TRISOMY 15Q	0.007554798999999999	0.2562509772902341
ERYTHROKERATODERMIA VARIABILIS	0.00751366	0.25485558491053706
OSTEOGLOSPHONIC DYSPLASIA	0.00751366	0.25485558491053706
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00751366	0.25485558491053706
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0074960240000000004	0.25425739001011805
SPINOCEREBELLAR ATAXIA 44; SCA44	0.007481150000000001	0.2537528792963036
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.007481150000000001	0.2537528792963036
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.007481150000000001	0.2537528792963036
SPINOCEREBELLAR ATAXIA 13	0.007481150000000001	0.2537528792963036
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.007481150000000001	0.2537528792963036
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.007481150000000001	0.2537528792963036
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.007481150000000001	0.2537528792963036
MULTIPLE METAPHYSEAL DYSPLASIA	0.007462099999999999	0.25310672297667425
OROFACIODIGITAL SYNDROME XVI; OFD16	0.007442104000000001	0.2524284793143485
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007442104000000001	0.2524284793143485
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007442104000000001	0.2524284793143485
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007442104000000001	0.2524284793143485
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.007442104000000001	0.2524284793143485
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007442104000000001	0.2524284793143485
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007437969000000001	0.252288224386177
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00742912	0.25198807544799323
FACIOCARDIORENAL SYNDROME	0.00742912	0.25198807544799323
TETRASOMY 18P	0.007426069	0.25188458867995184
2Q37 MICRODELETION SYNDROME	0.0074096529999999996	0.25132777491916264
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2512516946763842
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2512516946763842
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2512516946763842
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2512516946763842
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2512516946763842
KID SYNDROME	0.00740741	0.2512516946763842
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406244	0.2512121451609675
1Q21.1 MICRODELETION SYNDROME	0.007385633	0.25051304133399227
TETRASOMY 5P	0.007385633	0.25051304133399227
FRONTOOCULAR SYNDROME	0.007385203999999999	0.250498490097188
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007385203999999999	0.250498490097188
HADZISELIMOVIC SYNDROME	0.007385203999999999	0.250498490097188
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.24846026545661878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007305084	0.24778090246838497
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00728379	0.2470586319870104
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00728379	0.2470586319870104
INTERMEDIATE NEMALINE MYOPATHY	0.0072790500000000005	0.24689785608385859
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0072790500000000005	0.24689785608385859
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0072790500000000005	0.24689785608385859
NEUTRAL LIPID STORAGE MYOPATHY	0.0072790500000000005	0.24689785608385859
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0072790500000000005	0.24689785608385859
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0072790500000000005	0.24689785608385859
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0072790500000000005	0.24689785608385859
ALAGILLE SYNDROME	0.00726953	0.24657494751887843
CENANI-LENZ SYNDROME	0.00726953	0.24657494751887843
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00726953	0.24657494751887843
CINCA SYNDROME	0.007267633999999999	0.24651063715761767
ABRUZZO-ERICKSON SYNDROME	0.007264729999999999	0.24641213647771196
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.007264729999999999	0.24641213647771196
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.24637038222944618
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.24616724153662417
RING CHROMOSOME 13 SYNDROME	0.0071801899999999995	0.2435446270151682
RING CHROMOSOME 6 SYNDROME	0.0071801899999999995	0.2435446270151682
STROMME SYNDROME; STROMS	0.00717297	0.24329973207408037
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.24329973207408037
WAARDENBURG-SHAH SYNDROME	0.00717297	0.24329973207408037
WAARDENBURG SYNDROME	0.00717297	0.24329973207408037
ADULT SYNDROME	0.00717297	0.24329973207408037
DONNAI-BARROW SYNDROME	0.007165523	0.24304713752750406
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0071242	0.24164550405789562
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.0071242	0.24164550405789562
TREACHER COLLINS SYNDROME 3; TCS3	0.0071242	0.24164550405789562
TREACHER COLLINS SYNDROME 2; TCS2	0.0071242	0.24164550405789562
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0071242	0.24164550405789562
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0071242	0.24164550405789562
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.007095799999999999	0.24068220539766086
PTERYGIUM COLLI, ISOLATED	0.007095799999999999	0.24068220539766086
OROFACIAL CLEFT 15	0.007095799999999999	0.24068220539766086
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.23886584471964786
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.23886584471964786
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.23886584471964786
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.23886584471964786
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.23886584471964786
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.23886584471964786
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.23886584471964786
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.23886584471964786
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.23886584471964786
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.23886584471964786
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.23886584471964786
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.23886584471964786
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.23886584471964786
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.23886584471964786
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.23822999976595913
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019369	0.23808974483778764
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013809	0.23790115538176987
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.2378866041449656
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.2378866041449656
BARDET-BIEDL SYNDROME	0.00701338	0.2378866041449656
SECKEL SYNDROME 5; SCKL5	0.00701338	0.2378866041449656
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.2378866041449656
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.23662549695526391
ISOLATED CLEFT LIP	0.006976199999999999	0.23662549695526391
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.23662549695526391
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00697529	0.23659463069537612
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00695047	0.23575276193667805
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00689655	0.23392385124090848
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00689655	0.23392385124090848
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00689655	0.23392385124090848
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00689655	0.23392385124090848
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.00689655	0.23392385124090848
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00689655	0.23392385124090848
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888193000000001	0.23364039043444434
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006884650000000001	0.23352021553468336
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.006876283	0.23323641553855012
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.2329634017738941
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.2329634017738941
ADAMS-OLIVER SYNDROME 5; AOS5	0.006864098999999999	0.2328231468457226
LOEYS-DIETZ SYNDROME 5	0.006860689999999999	0.23270751708752754
MILLER-DIEKER SYNDROME	0.006845639	0.23219700271657007
CEREBROOCULONASAL SYNDROME	0.006839649999999999	0.231993862023748
BALLER-GEROLD SYNDROME	0.006839649999999999	0.231993862023748
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23009589231135033
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.22995563738317884
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00673116	0.22831399330371757
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00673116	0.22831399330371757
JOUBERT SYNDROME 24	0.006696534	0.22713951515550318
EHLERS-DANLOS SYNDROME, TYPE VI	0.006686959999999999	0.22681477496630997
COSTELLO SYNDROME; CSTLO	0.006684624	0.22673554025960901
DISTAL MONOSOMY 6P	0.006684624	0.22673554025960901
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184000000001	0.226177912443614
15Q OVERGROWTH SYNDROME	0.006664049	0.22603765751544247
KABUKI SYNDROME 1	0.006635843000000001	0.22508093913478824
MICRO SYNDROME	0.006635843000000001	0.22508093913478824
2Q31.1 MICRODELETION SYNDROME	0.006572523	0.22293319015006768
WALKER-WARBURG SYNDROME	0.006551453	0.2222185175172809
ADAMS-OLIVER SYNDROME 2; AOS2	0.006551453	0.2222185175172809
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.006487983000000001	0.22006568068752394
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0064762529999999995	0.2196678112056734
FANCONI ANEMIA	0.006450374	0.21879002226101799
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.006450373999999999	0.21879002226101793
ICF SYNDROME	0.006450373999999999	0.21879002226101793
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.006450373999999999	0.21879002226101793
DISTAL MONOSOMY 3P	0.0064462389999999994	0.21864976733284644
KAGAMI-OGATA SYNDROME	0.006406123	0.21728907405629802
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.006406123	0.21728907405629802
WILSON-TURNER SYNDROME	0.006406123	0.21728907405629802
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006406123	0.21728907405629802
PALLISTER-HALL SYNDROME	0.006406123	0.21728907405629802
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.006366759999999999	0.2159539217618325
BASAL CELL NEVUS SYNDROME	0.006366759999999999	0.2159539217618325
ELSAHY-WATERS SYNDROME; ESWS	0.0063644240000000005	0.21587468705513155
3C SYNDROME	0.0063644240000000005	0.21587468705513155
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.21513576236100435
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006295303	0.213530174143368
MEND SYNDROME; MEND	0.006295303	0.213530174143368
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006295303	0.213530174143368
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.006295303	0.213530174143368
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.006295303	0.213530174143368
MEND SYNDROME	0.006295303	0.213530174143368
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006295303	0.213530174143368
15Q14 MICRODELETION SYNDROME	0.006295303	0.213530174143368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0062953029999999995	0.213530174143368
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21159126423791033
FRASER SYNDROME	0.00623814	0.21159126423791033
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21159126423791033
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006215183000000001	0.21081258651456503
PETTIGREW SYNDROME	0.006215183000000001	0.21081258651456503
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.006215183000000001	0.21081258651456503
XQ21 MICRODELETION SYNDROME	0.006215183000000001	0.21081258651456503
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183	0.21081258651456497
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.006178964	0.20958407545206356
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006166573	0.20916378553308573
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.2086348870820632
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.2086348870820632
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.2086348870820632
MIRAGE SYNDROME; MIRAGE	0.006142613	0.20835108708592998
CHROMOSOME 18P DELETION SYNDROME	0.006094424	0.20671656598951973
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0060902890000000005	0.20657631106134824
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.20617813630879556
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.006013083000000001	0.20395756330212003
AICARDI-GOUTIÈRES SYNDROME	0.006013083000000001	0.20395756330212003
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006013083	0.20395756330211998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.006013083	0.20395756330211998
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.006013083	0.20395756330211998
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.006010034	0.20385414437201235
CHAR SYNDROME	0.006010034	0.20385414437201235
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006010034	0.20385414437201235
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.006010034	0.20385414437201235
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.006010034	0.20385414437201235
BRESEK SYNDROME	0.006010034	0.20385414437201235
HARROD SYNDROME	0.006005899	0.20371388944384086
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.006005899	0.20371388944384086
16Q24.3 MICRODELETION SYNDROME	0.006005899	0.20371388944384086
FRAGILE X SYNDROME	0.006005899	0.20371388944384086
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0059489	0.2017805422489564
OPITZ G/BBB SYNDROME	0.0059465640000000005	0.20170130754225543
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0059465640000000005	0.20170130754225543
JOUBERT SYNDROME 10	0.0059465640000000005	0.20170130754225543
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00593717	0.20138267276710595
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00593717	0.20138267276710595
PROTEUS SYNDROME	0.005930698999999999	0.20116318313223341
PROGEROID SYNDROME, PETTY TYPE	0.00590482	0.200285394187578
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00590482	0.200285394187578
RING CHROMOSOME 12 SYNDROME	0.005864704	0.19892470091102954
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005864704	0.19892470091102954
MEIER-GORLIN SYNDROME 7	0.005864704	0.19892470091102954
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.005864704	0.19892470091102954
EVEN-PLUS SYNDROME	0.005864704	0.19892470091102954
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.005864704	0.19892470091102954
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0058605689999999995	0.198784445982858
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0058605689999999995	0.198784445982858
3-HYDROXYISOBUTYRIC ACIDURIA	0.0058605689999999995	0.198784445982858
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.1980478616974476
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00581887	0.19737005898169158
CRANIOFRONTONASAL DYSPLASIA	0.00581887	0.19737005898169158
GENITOPALATOCARDIAC SYNDROME	0.00581887	0.19737005898169158
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19677138921573584
BEHR SYNDROME	0.00580122	0.19677138921573584
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19677138921573584
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19677138921573584
DYSTONIA 16; DYT16	0.00580122	0.19677138921573584
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19677138921573584
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19677138921573584
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19677138921573584
MAST SYNDROME	0.00580122	0.19677138921573584
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0057611039999999995	0.19541069593918733
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057611039999999995	0.19541069593918733
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0057598729999999996	0.19536894169092153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0057598729999999996	0.19536894169092153
CENTRAL BILATERAL MACROGYRIA	0.0057598729999999996	0.19536894169092153
SEVERE CANAVAN DISEASE	0.0057598729999999996	0.19536894169092153
CANAVAN DISEASE	0.0057598729999999996	0.19536894169092153
VICI SYNDROME	0.0057598729999999996	0.19536894169092153
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0057598729999999996	0.19536894169092153
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0057598729999999996	0.19536894169092153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0057598729999999996	0.19536894169092153
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.0057598729999999996	0.19536894169092153
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.0057598729999999996	0.19536894169092153
HARTNUP DISEASE	0.0057598729999999996	0.19536894169092153
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0057598729999999996	0.19536894169092153
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0057598729999999996	0.19536894169092153
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0057598729999999996	0.19536894169092153
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0057598729999999996	0.19536894169092153
TAY-SACHS DISEASE	0.0057598729999999996	0.19536894169092153
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0057598729999999996	0.19536894169092153
SCHIZENCEPHALY	0.0057598729999999996	0.19536894169092153
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.19536894169092153
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.005756969	0.19527044101101587
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.19516580099809952
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.19516580099809952
DISTAL TRISOMY 18Q	0.005753884	0.19516580099809952
12Q14 MICRODELETION SYNDROME	0.005753884	0.19516580099809952
ALAZAMI-YUAN SYNDROME	0.005753884	0.19516580099809952
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.19516580099809952
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.19502554606992803
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.19244821336929652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.005673764	0.19244821336929652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005673764	0.19244821336929652
MARINESCO-SJOGREN SYNDROME; MSS	0.005673764	0.19244821336929652
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.19244821336929652
SPINOCEREBELLAR ATAXIA 5; SCA5	0.005673764	0.19244821336929652
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.19230795844112503
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.005669629000000001	0.19230795844112503
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005669629000000001	0.19230795844112503
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.19230795844112503
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.19230795844112503
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005669629000000001	0.19230795844112503
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.005669629000000001	0.19230795844112503
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.005669629000000001	0.19230795844112503
HUNTINGTON DISEASE; HD	0.005669629000000001	0.19230795844112503
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.191477316860474
GORLIN SYNDROME	0.00564514	0.191477316860474
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.191477316860474
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.191477316860474
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.191477316860474
SAUL-WILSON SYNDROME; SWILS	0.005601194	0.1899867139406615
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005601194	0.1899867139406615
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.18984645901248998
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00554887	0.18821193791607974
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00554887	0.18821193791607974
SHORT SYNDROME	0.00554887	0.18821193791607974
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00554887	0.18821193791607974
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00554887	0.18821193791607974
LERI PLEONOSTEOSIS	0.00549746	0.18646816382725342
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.18646816382725342
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.18646816382725342
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0054855500000000005	0.18606418893135923
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005471664	0.1855931901568515
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.005471664	0.1855931901568515
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.005471664	0.1855931901568515
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.005471664	0.1855931901568515
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.005471664	0.1855931901568515
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0054675290000000005	0.18545293522868
SECONDARY SYRINGOMYELIA	0.0054675290000000005	0.18545293522868
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00546448	0.18534951629857238
LIMB-MAMMARY SYNDROME	0.00546448	0.18534951629857238
BLOOM SYNDROME	0.00546448	0.18534951629857238
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00546448	0.18534951629857238
WOODHOUSE-SAKATI SYNDROME	0.00546448	0.18534951629857238
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00546448	0.18534951629857238
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00546448	0.18534951629857238
WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	0.00546448	0.18534951629857238
3M SYNDROME	0.00546448	0.18534951629857238
CRANIOECTODERMAL DYSPLASIA 4	0.00546448	0.18534951629857238
WEAVER-WILLIAMS SYNDROME	0.00546448	0.18534951629857238
SCHIZOPHRENIA 1; SCZD1	0.00546448	0.18534951629857238
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00546448	0.18534951629857238
RODRIGUES BLINDNESS	0.00546448	0.18534951629857238
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00546448	0.18534951629857238
THREE M SYNDROME 2; 3M2	0.00546448	0.18534951629857238
TRISOMY 5P	0.00546448	0.18534951629857238
BLOOM SYNDROME	0.00546448	0.18534951629857238
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00546448	0.18534951629857238
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420993	0.18387448218457142
49,XXXXY SYNDROME	0.005420993	0.18387448218457142
48,XXXY SYNDROME	0.005420993	0.18387448218457142
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420993	0.18387448218457142
8P11.2 DELETION SYNDROME	0.005420993	0.18387448218457142
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.18360065436470963
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00540101	0.18319667946881543
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00540101	0.18319667946881543
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00538928	0.18279880998696493
SIALIDOSIS TYPE 2	0.005360472999999999	0.18182170630719796
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.18182170630719796
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.18182170630719796
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.18182170630719796
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.18182170630719796
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.18182170630719796
HEMIFACIAL MICROSOMIA	0.00531915	0.18042007283758954
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00531915	0.18042007283758954
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00531915	0.18042007283758954
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00531915	0.18042007283758954
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00531915	0.18042007283758954
MICROTIA - EYE COLOBOMA - IMPERFORATION OF THE NASOLACRIMAL DUCT	0.00531915	0.18042007283758954
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00531915	0.18042007283758954
CHANARIN-DORFMAN SYNDROME	0.00531915	0.18042007283758954
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00531915	0.18042007283758954
DIABETIC EMBRYOPATHY	0.00531915	0.18042007283758954
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00531915	0.18042007283758954
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00531915	0.18042007283758954
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00531915	0.18042007283758954
COXOAURICULAR SYNDROME	0.00531915	0.18042007283758954
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00531915	0.18042007283758954
MEIER-GORLIN SYNDROME 8; MGORS8	0.00531915	0.18042007283758954
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00531915	0.18042007283758954
COXOAURICULAR SYNDROME	0.00531915	0.18042007283758954
MICROTIA-ANOTIA	0.00531915	0.18042007283758954
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00531915	0.18042007283758954
OCULOAURICULOFRONTONASAL SYNDROME	0.00531915	0.18042007283758954
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.00531915	0.18042007283758954
DISTAL MONOSOMY 17Q	0.00531915	0.18042007283758954
MEIER-GORLIN SYNDROME 2; MGORS2	0.00531915	0.18042007283758954
HAND-FOOT-GENITAL SYNDROME	0.00531915	0.18042007283758954
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00531915	0.18042007283758954
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00531915	0.18042007283758954
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00531915	0.18042007283758954
OTOMANDIBULAR SYNDROME	0.00531915	0.18042007283758954
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.00531915	0.18042007283758954
ISOLATED ARRHINIA	0.00531915	0.18042007283758954
ISOTRETINOIN SYNDROME	0.00531915	0.18042007283758954
DIAMOND-BLACKFAN ANEMIA 10	0.00531915	0.18042007283758954
GOLDENHAR SYNDROME	0.00531915	0.18042007283758954
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00531915	0.18042007283758954
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.1779037264394616
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.17700456854565308
ACHALASIA-MICROCEPHALY SYNDROME	0.005215549999999999	0.17690606786574736
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.005215549999999999	0.17690606786574736
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.1768643136174816
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.1768643136174816
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.1768643136174816
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.1768643136174816
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.1768643136174816
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.1768643136174816
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.1768643136174816
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.1768643136174816
AUTISM	0.005214319	0.1768643136174816
BANGSTAD SYNDROME	0.005214319	0.1768643136174816
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.1768643136174816
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.1768643136174816
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.1768643136174816
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.1768643136174816
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.1768643136174816
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.1768643136174816
XERODERMA PIGMENTOSUM	0.005214319	0.1768643136174816
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.1768643136174816
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.1768643136174816
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.1768643136174816
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.1768643136174816
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.1768643136174816
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.1768643136174816
KRABBE DISEASE	0.005214319	0.1768643136174816
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.1768643136174816
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.1768643136174816
EPILEPSY, READING	0.005214319	0.1768643136174816
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.1768643136174816
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.1768643136174816
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.1768643136174816
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.1768643136174816
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.1768643136174816
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.1768643136174816
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.17666117292465955
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.17666117292465955
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.17666117292465955
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.17666117292465955
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.17666117292465955
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.17666117292465955
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.17666117292465955
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.1739435852958565
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 28	0.00512821	0.1739435852958565
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 14	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 23	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 18	0.00512821	0.1739435852958565
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 25	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 2	0.00512821	0.1739435852958565
MULTIPLE SYSTEM ATROPHY	0.00512821	0.1739435852958565
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00512821	0.1739435852958565
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.1739435852958565
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.1739435852958565
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00512821	0.1739435852958565
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 14	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00512821	0.1739435852958565
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 15	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 26	0.00512821	0.1739435852958565
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.1739435852958565
SUSAC SYNDROME	0.00512821	0.1739435852958565
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00512821	0.1739435852958565
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 30	0.00512821	0.1739435852958565
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 31	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00512821	0.1739435852958565
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00512821	0.1739435852958565
BOUCHER-NEUHAUSER SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.1739435852958565
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 20	0.00512821	0.1739435852958565
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00512821	0.1739435852958565
ARNOLD-CHIARI MALFORMATION TYPE I	0.00512821	0.1739435852958565
MYOTONIA PERMANENS	0.0050796	0.17229478431437728
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.1714820858672215
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.1714820858672215
CENTRAL CORE DISEASE	0.00505564	0.1714820858672215
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.1676797357576802
MUENKE SYNDROME	0.004941203	0.1676005010509792
RUVALCABA SYNDROME	0.004941203	0.1676005010509792
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00492611	0.1670885620834115
CONGENITAL PATELLA DISLOCATION	0.00492611	0.1670885620834115
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00492611	0.1670885620834115
IMMUNODEFICIENCY 9; IMD9	0.00492611	0.1670885620834115
SPINOCEREBELLAR ATAXIA TYPE 36	0.00492611	0.1670885620834115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.00492611	0.1670885620834115
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00492611	0.1670885620834115
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00492611	0.1670885620834115
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.00492611	0.1670885620834115
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00492611	0.1670885620834115
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00492611	0.1670885620834115
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00492611	0.1670885620834115
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00492611	0.1670885620834115
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.00492611	0.1670885620834115
POSTERIOR MENINGOCELE	0.00492611	0.1670885620834115
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00492611	0.1670885620834115
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.00492611	0.1670885620834115
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.00492611	0.1670885620834115
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00492611	0.1670885620834115
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00492611	0.1670885620834115
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00492611	0.1670885620834115
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00492611	0.1670885620834115
WILSON DISEASE	0.00492611	0.1670885620834115
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00492611	0.1670885620834115
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00492611	0.1670885620834115
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00492611	0.1670885620834115
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00492611	0.1670885620834115
PRIMARY DYSTONIA, DYT2 TYPE	0.00492611	0.1670885620834115
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00492611	0.1670885620834115
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00492611	0.1670885620834115
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00492611	0.1670885620834115
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00492611	0.1670885620834115
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00492611	0.1670885620834115
ADULT-ONSET NEMALINE MYOPATHY	0.00492611	0.1670885620834115
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00492611	0.1670885620834115
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00492611	0.1670885620834115
DIAPHANOSPONDYLODYSOSTOSIS	0.004879573999999999	0.1655101090393029
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.1655101090393029
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.1655101090393029
MARDEN-WALKER SYNDROME	0.004875439	0.16536985411113142
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875439	0.16536985411113142
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.16495248122330788
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858999	0.1648122262951364
COG5-CDG	0.004858999	0.1648122262951364
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663000000001	0.1647329915884354
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663000000001	0.1647329915884354
ZTTK SYNDROME; ZTTKS	0.004856663000000001	0.1647329915884354
3Q29 MICRODUPLICATION SYNDROME	0.004856663000000001	0.1647329915884354
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192948
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192948
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.16345733316192948
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192948
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.16345733316192948
CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192948
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192948
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.16345733316192948
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.16345733316192948
THYROID ECTOPIA	0.004819054	0.16345733316192948
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.16345733316192948
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.16345733316192948
THYROID HEMIAGENESIS	0.004819054	0.16345733316192948
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.16331707823375796
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.16331707823375796
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.16331707823375796
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.16331707823375796
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.16331707823375796
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.16117886047873908
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.16117886047873908
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.16117886047873908
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.16117886047873908
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.16117886047873908
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.16117886047873908
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.16117886047873908
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.16117886047873908
ATELOSTEOGENESIS TYPE I	0.00475188	0.16117886047873908
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.16117886047873908
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.16117886047873908
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.16117886047873908
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.1593990983660216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.1593990983660216
CONGENITAL HYDROCEPHALUS	0.004699409	0.1593990983660216
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.1593990983660216
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.004682933	0.15884024946721784
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.15884024946721784
C SYNDROME	0.004682933	0.15884024946721784
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.15884024946721784
SIALURIA	0.004682933	0.15884024946721784
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.15884024946721784
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.15884024946721784
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.15884024946721784
COFFIN-SIRIS SYNDROME	0.004682933	0.15884024946721784
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.15849994047221308
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.15849994047221308
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.15849994047221308
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.15849994047221308
SCHIZOPHRENIA	0.0046729	0.15849994047221308
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.15849994047221308
ARGININOSUCCINIC ACIDURIA	0.0046729	0.15849994047221308
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.15849994047221308
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.15849994047221308
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.15849994047221308
SACCHAROPINURIA	0.0046729	0.15849994047221308
ISAAC SYNDROME	0.0046729	0.15849994047221308
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.15849994047221308
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.15849994047221308
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.0046712030000000005	0.15844237998536737
11P15.4 MICRODUPLICATION SYNDROME	0.0046712030000000005	0.15844237998536737
KBG SYNDROME	0.0046712030000000005	0.15844237998536737
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0046712030000000005	0.15844237998536737
SSR4-CDG	0.0046712030000000005	0.15844237998536737
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0046712030000000005	0.15844237998536737
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0046712030000000005	0.15844237998536737
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0046712030000000005	0.15844237998536737
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.0046712030000000005	0.15844237998536737
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0046712030000000005	0.15844237998536737
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0046712030000000005	0.15844237998536737
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.0046712030000000005	0.15844237998536737
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536737
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0046712030000000005	0.15844237998536737
HOLOPROSENCEPHALY 7	0.0046712030000000005	0.15844237998536737
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0046712030000000005	0.15844237998536737
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0046712030000000005	0.15844237998536737
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0046712030000000005	0.15844237998536737
MACDERMOT-WINTER SYNDROME	0.0046712030000000005	0.15844237998536737
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.15831135101619528
FLOATING-HARBOR SYNDROME	0.004559374	0.15464925583482547
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.15450900090665398
L1 SYNDROME	0.004535253	0.15383109643399726
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.15383109643399726
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.15383109643399726
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.15383109643399726
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.15383109643399726
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.15383109643399726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.15383109643399726
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.15383109643399726
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.15383109643399726
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.15383109643399726
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.15383109643399726
16P13.2 MICRODELETION SYNDROME	0.004535253	0.15383109643399726
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004529814	0.15364661117297554
15Q11Q13 MICRODUPLICATION SYNDROME	0.004523343000000001	0.15342712153810306
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004523343000000001	0.15342712153810306
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004523343000000001	0.15342712153810306
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.004523343000000001	0.15342712153810306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004523343000000001	0.15342712153810306
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004523343000000001	0.15342712153810306
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.1528982230870805
LARON SYNDROME	0.00440212	0.14931536261241168
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.14931536261241168
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.14931536261241168
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.14931536261241168
OCCIPITAL HORN SYNDROME	0.004399784	0.1492361279057107
THANATOPHORIC DYSPLASIA	0.004395649	0.1490958729775392
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.1490958729775392
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.1490958729775392
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.1470054809658629
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.004334019999999999	0.1470054809658629
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.004334019999999999	0.1470054809658629
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.004334019999999999	0.1470054809658629
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.1464478531498679
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.1464478531498679
HEREDITARY OROTIC ACIDURIA	0.004315244	0.14636861844316693
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.14622836351499544
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.14495270508848948
COOPER-JABS SYNDROME	0.0042734999999999995	0.14495270508848948
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.14495270508848948
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.14495270508848948
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.14495270508848948
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.14495270508848948
GAPO SYNDROME	0.0042734999999999995	0.14495270508848948
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.14495270508848948
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.14495270508848948
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.14495270508848948
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.14495270508848948
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.14495270508848948
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.14495270508848948
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.14495270508848948
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.14495270508848948
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.14495270508848948
ACHONDROGENESIS	0.0042734999999999995	0.14495270508848948
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.14495270508848948
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.14495270508848948
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.14495270508848948
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.14495270508848948
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.14495270508848948
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.14495270508848948
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.14495270508848948
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.14495270508848948
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.14495270508848948
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.14495270508848948
BLADDER EXSTROPHY	0.0042734999999999995	0.14495270508848948
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.14495270508848948
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.14495270508848948
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.14495270508848948
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.14495270508848948
OROFACIODIGITAL SYNDROME VI	0.004226054	0.14334338578449313
TETRASOMY X	0.004226054	0.14334338578449313
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.14334338578449313
BARATELA-SCOTT SYNDROME	0.004226054	0.14334338578449313
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.1432031308563216
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.14103472522075314
SOTOS SYNDROME 2	0.00415799	0.14103472522075314
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.14103472522075314
LIG4 SYNDROME	0.004141514	0.14047587632194933
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004141514	0.14047587632194933
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.14047587632194933
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.14047587632194933
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.14047587632194933
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.14047587632194933
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004137379	0.14033562139377784
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004137379	0.14033562139377784
ARTERIAL TORTUOSITY SYNDROME	0.004129784	0.14007800684009888
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004129784	0.14007800684009888
OPTIC ATROPHY 11; OPA11	0.004129784	0.14007800684009888
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.004129784	0.14007800684009888
HOLOPROSENCEPHALY 5; HPE5	0.004129784	0.14007800684009888
MENTAL RETARDATION, X-LINKED 107; MRX107	0.004129784	0.14007800684009888
HYPOTONIA-CYSTINURIA SYNDROME	0.004129784	0.14007800684009888
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.004125649	0.1399377519119274
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004125649	0.1399377519119274
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.004125649	0.1399377519119274
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.004125649	0.1399377519119274
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.004125649	0.1399377519119274
WARBURG MICRO SYNDROME 3; WARBM3	0.004125649	0.1399377519119274
FRAGILE X MENTAL RETARDATION SYNDROME	0.004125649	0.1399377519119274
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.13614462776138547
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.13614462776138547
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.13614462776138547
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.13614462776138547
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.13614462776138547
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.13614462776138547
SHORT SYNDROME	0.0040138199999999995	0.13614462776138547
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.13614462776138547
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.13614462776138547
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.13614462776138547
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.13614462776138547
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13546672328872877
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.13546672328872877
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13546672328872877
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.13546672328872877
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13546672328872877
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13546672328872877
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13546672328872877
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.13546672328872877
RIDDLE SYNDROME	0.003993834	0.13546672328872877
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13546672328872877
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13546672328872877
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.13546672328872877
BEHÇET DISEASE	0.003989699	0.13532646836055728
KALLMANN SYNDROME	0.003989699	0.13532646836055728
ALZHEIMER DISEASE 3; AD	0.003989699	0.13532646836055728
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13532646836055728
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.13532646836055728
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13532646836055728
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13532646836055728
SUBEPENDYMOMA	0.003989699	0.13532646836055728
EPENDYMOMA	0.003989699	0.13532646836055728
ATAXIA-TELANGIECTASIA	0.003989699	0.13532646836055728
KUFOR-RAKEB SYNDROME	0.003989699	0.13532646836055728
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13532646836055728
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.13532646836055728
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13532646836055728
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13532646836055728
CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055728
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055728
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13532646836055728
TENORIO SYNDROME; TNORS	0.003989699	0.13532646836055728
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13532646836055728
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.13532646836055728
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13532646836055728
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13532646836055728
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13532646836055728
LYNCH SYNDROME	0.003989699	0.13532646836055728
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00398426	0.13514198309953554
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00398426	0.13514198309953554
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.003981924	0.13506274839283455
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003981924	0.13506274839283455
CUTIS LAXA	0.003981924	0.13506274839283455
NOONAN SYNDROME 5; NS5	0.003981924	0.13506274839283455
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003981924	0.13506274839283455
NOONAN SYNDROME 3; NS3	0.003981924	0.13506274839283455
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.13073149983227073
FIBROCHONDROGENESIS	0.00385423	0.13073149983227073
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.13073149983227073
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.13073149983227073
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0037896729999999995	0.1285417930854829
1Q21.1 MICRODUPLICATION SYNDROME	0.0037896729999999995	0.1285417930854829
DISTAL MONOSOMY 15Q	0.0037896729999999995	0.1285417930854829
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0037896729999999995	0.1285417930854829
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.1285417930854829
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.12786399036972693
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.12786399036972693
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.12786399036972693
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.12786399036972693
RING CHROMOSOME 1 SYNDROME	0.00376969	0.12786399036972693
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.12786399036972693
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.12786399036972693
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.12786399036972693
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.12786399036972693
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.12483875771105313
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0036804999999999997	0.12483875771105313
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.12483875771105313
JACOBSEN SYNDROME	0.0036804999999999997	0.12483875771105313
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.12483875771105313
SILLENCE SYNDROME	0.0036804999999999997	0.12483875771105313
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.12483875771105313
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.12483875771105313
CRANIOECTODERMAL DYSPLASIA	0.0036804999999999997	0.12483875771105313
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.12483875771105313
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.12483875771105313
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.12483875771105313
SUMMITT SYNDROME	0.0036804999999999997	0.12483875771105313
FRONTORHINY	0.0036804999999999997	0.12483875771105313
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.0036804999999999997	0.12483875771105313
VELO-FACIAL-SKELETAL SYNDROME	0.00359596	0.12197124824850936
3Q13 MICRODELETION SYNDROME	0.00359596	0.12197124824850936
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.12197124824850936
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.12197124824850936
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.12197124824850936
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.12197124824850936
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.12197124824850936
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00358423	0.12157337876665887
ATKIN-FLAITZ SYNDROME	0.00358423	0.12157337876665887
SAY SYNDROME	0.00358423	0.12157337876665887
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00358423	0.12157337876665887
WARBURG MICRO SYNDROME 1	0.00358423	0.12157337876665887
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00358423	0.12157337876665887
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00358423	0.12157337876665887
DERMATOLEUKODYSTROPHY	0.00358423	0.12157337876665887
LAMBOTTE SYNDROME	0.00358423	0.12157337876665887
THAKKER-DONNAI SYNDROME	0.00358423	0.12157337876665887
NIJMEGEN BREAKAGE SYNDROME	0.00358423	0.12157337876665887
HOLZGREVE SYNDROME	0.00358423	0.12157337876665887
NAKAJO-NISHIMURA SYNDROME	0.00358423	0.12157337876665887
601095 HARROD SYNDROME	0.00358423	0.12157337876665887
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00358423	0.12157337876665887
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00358423	0.12157337876665887
NEU-LAXOVA SYNDROME	0.00358423	0.12157337876665887
SOMATOMAMMOTROPINOMA	0.00358423	0.12157337876665887
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00358423	0.12157337876665887
ALAGILLE SYNDROME 1; ALGS1	0.00358423	0.12157337876665887
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00358423	0.12157337876665887
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00358423	0.12157337876665887
ACROMEGALY	0.00358423	0.12157337876665887
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11696209521528879
PSEUDOACHONDROPLASIA	0.00344828	0.11696209521528879
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528879
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11696209521528879
CLASSIC GALACTOSEMIA	0.00344828	0.11696209521528879
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11696209521528879
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11696209521528879
POLYMYOSITIS	0.00344828	0.11696209521528879
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11696209521528879
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11696209521528879
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11696209521528879
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11696209521528879
DYSTONIA 23; DYT23	0.00344828	0.11696209521528879
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11696209521528879
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11696209521528879
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11696209521528879
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11696209521528879
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11696209521528879
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11696209521528879
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11696209521528879
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11696209521528879
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11696209521528879
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11696209521528879
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11696209521528879
BENIGN HEREDITARY CHOREA	0.00344828	0.11696209521528879
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11696209521528879
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11696209521528879
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11696209521528879
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11696209521528879
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11696209521528879
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11696209521528879
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11696209521528879
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11696209521528879
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11696209521528879
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11696209521528879
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11696209521528879
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11696209521528879
THORACOMELIC DYSPLASIA	0.00344828	0.11696209521528879
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11696209521528879
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11696209521528879
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11696209521528879
CYSTINOSIS	0.00344828	0.11696209521528879
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11696209521528879
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11696209521528879
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11696209521528879
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11696209521528879
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11696209521528879
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11696209521528879
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11696209521528879
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11696209521528879
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11696209521528879
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11696209521528879
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11696209521528879
KENNEDY DISEASE	0.00344828	0.11696209521528879
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11696209521528879
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11696209521528879
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11696209521528879
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11696209521528879
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11696209521528879
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11696209521528879
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11696209521528879
NONAKA MYOPATHY	0.00344828	0.11696209521528879
NEMALINE MYOPATHY 6	0.00344828	0.11696209521528879
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11696209521528879
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11696209521528879
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11696209521528879
MANGANESE POISONING	0.00344828	0.11696209521528879
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11696209521528879
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11696209521528879
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11696209521528879
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11696209521528879
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11696209521528879
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11696209521528879
MASA SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11696209521528879
ROUSSY-LÉVY SYNDROME	0.00344828	0.11696209521528879
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11696209521528879
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11696209521528879
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11696209521528879
SPONASTRIME DYSPLASIA	0.00344828	0.11696209521528879
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11696209521528879
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11696209521528879
MYOTONIA FLUCTUANS	0.00344828	0.11696209521528879
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11696209521528879
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11696209521528879
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11696209521528879
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.003439913	0.11667829521915556
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003439913	0.11667829521915556
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003439913	0.11667829521915556
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.003439913	0.11667829521915556
KETOADIPICACIDURIA	0.003439913	0.11667829521915556
VICI SYNDROME; VICIS	0.003439913	0.11667829521915556
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.003439913	0.11667829521915556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003439913	0.11667829521915556
PRADER-WILLI SYNDROME; PWS	0.003439913	0.11667829521915556
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0034363700000000002	0.11655812031939458
NOONAN SYNDROME 8; NS8	0.0034363700000000002	0.11655812031939458
DIAMOND-BLACKFAN ANEMIA 1	0.0034363700000000002	0.11655812031939458
8Q21.11 MICRODELETION SYNDROME	0.0034363700000000002	0.11655812031939458
GMS SYNDROME	0.0034363700000000002	0.11655812031939458
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0034363700000000002	0.11655812031939458
LEGIUS SYNDROME	0.0034363700000000002	0.11655812031939458
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0034363700000000002	0.11655812031939458
ACRORENAL-MANDIBULAR SYNDROME	0.0034363700000000002	0.11655812031939458
NOONAN SYNDROME 4; NS4	0.0034363700000000002	0.11655812031939458
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11017741994021443
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11017741994021443
RAHMAN SYNDROME	0.003248254	0.11017741994021443
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11017741994021443
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11017741994021443
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11017741994021443
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11017741994021443
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11017741994021443
LARSEN-LIKE SYNDROME	0.003248254	0.11017741994021443
ATELOSTEOGENESIS TYPE III	0.003248254	0.11017741994021443
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11017741994021443
MOSAIC TRISOMY 9	0.003248254	0.11017741994021443
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.11003716501204293
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.11003716501204293
CYSTATHIONINURIA	0.0032441189999999997	0.11003716501204293
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.11003716501204293
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.11003716501204293
GRACILE BONE DYSPLASIA; GCLEB	0.003136153	0.10637506983067313
COWDEN SYNDROME	0.003136153	0.10637506983067313
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.10637506983067313
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.003136153	0.10637506983067313
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003051613	0.10350756036812932
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003051613	0.10350756036812932
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.10350756036812932
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.10350756036812932
BOHRING-OPITZ SYNDROME	0.003051613	0.10350756036812932
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.10350756036812932
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.10350756036812932
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.10350756036812932
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.10350756036812932
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09831392207388703
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09831392207388703
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09831392207388703
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09831392207388703
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09831392207388703
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09831392207388703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09831392207388703
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09831392207388703
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09831392207388703
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09817366714571554
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09817366714571554
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09817366714571554
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09817366714571554
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09817366714571554
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09817366714571554
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09817366714571554
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09817366714571554
LISSENCEPHALY 3; LIS3	0.002894359	0.09817366714571554
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09817366714571554
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09817366714571554
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09817366714571554
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09817366714571554
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09817366714571554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09817366714571554
47,XYY SYNDROME	0.002894359	0.09817366714571554
PRADER-WILLI SYNDROME	0.002894359	0.09817366714571554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09817366714571554
CYCLIC VOMITING SYNDROME	0.002894359	0.09817366714571554
CAMOS SYNDROME	0.002894359	0.09817366714571554
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0028920230000000005	0.09809443243901457
GABA-TRANSAMINASE DEFICIENCY	0.0028920230000000005	0.09809443243901457
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0028920230000000005	0.09809443243901457
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0028920230000000005	0.09809443243901457
LUSCAN-LUMISH SYNDROME; LLS	0.0028920230000000005	0.09809443243901457
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0028920230000000005	0.09809443243901457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0028920230000000005	0.09809443243901457
MEVALONIC ACIDURIA	0.0028920230000000005	0.09809443243901457
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0028920230000000005	0.09809443243901457
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0028920230000000005	0.09809443243901457
611961 STEVENSON-CAREY SYNDROME	0.0028920230000000005	0.09809443243901457
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.09220169031779699
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.09220169031779699
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.09220169031779699
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.09220169031779699
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.09220169031779699
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.09220169031779699
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002718293	0.09220169031779699
TRISOMY X	0.002718293	0.09220169031779699
DISTAL MONOSOMY 1Q	0.002718293	0.09220169031779699
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.09220169031779699
19P13.12 MICRODELETION SYNDROME	0.002718293	0.09220169031779699
XQ25 DUPLICATION SYNDROME	0.002718293	0.09220169031779699
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.09220169031779699
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.002718293	0.09220169031779699
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002718293	0.09220169031779699
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09167279186677443
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09167279186677443
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09167279186677443
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09167279186677443
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09167279186677443
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09167279186677443
BRUCK SYNDROME 2	0.0027026999999999997	0.09167279186677443
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09167279186677443
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09167279186677443
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09167279186677443
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09167279186677443
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09167279186677443
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09167279186677443
INIENCEPHALY	0.0027026999999999997	0.09167279186677443
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09167279186677443
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09167279186677443
BRUCK SYNDROME	0.0027026999999999997	0.09167279186677443
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09167279186677443
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677443
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09167279186677443
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09167279186677443
CLOACAL EXSTROPHY	0.0027026999999999997	0.09167279186677443
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09167279186677443
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09167279186677443
TIBIAL HEMIMELIA	0.0027026999999999997	0.09167279186677443
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09167279186677443
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677443
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09167279186677443
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09167279186677443
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09167279186677443
RENAL AGENESIS	0.0027026999999999997	0.09167279186677443
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677443
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09167279186677443
LAMBERT SYNDROME	0.0027026999999999997	0.09167279186677443
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09167279186677443
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677443
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677443
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09167279186677443
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09167279186677443
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09167279186677443
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09167279186677443
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09167279186677443
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09167279186677443
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09167279186677443
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09167279186677443
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09167279186677443
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09167279186677443
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09167279186677443
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09167279186677443
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09167279186677443
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09167279186677443
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09167279186677443
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09167279186677443
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09167279186677443
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09167279186677443
NIEVERGELT SYNDROME	0.0027026999999999997	0.09167279186677443
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09167279186677443
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09167279186677443
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09167279186677443
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09167279186677443
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09167279186677443
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09167279186677443
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09167279186677443
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09167279186677443
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09167279186677443
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09167279186677443
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08801069668540462
TEMTAMY SYNDROME	0.0025947339999999996	0.08801069668540462
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08801069668540462
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08801069668540462
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08801069668540462
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08801069668540462
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08801069668540462
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540462
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540462
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08801069668540462
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08801069668540462
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08801069668540462
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08801069668540462
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08801069668540462
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08787044175723313
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08787044175723313
CRANIOSYNOSTOSIS 2	0.002590599	0.08787044175723313
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08787044175723313
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08787044175723313
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08787044175723313
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08514318722286085
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08514318722286085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08514318722286085
STEEL SYNDROME; STLS	0.0025101940000000003	0.08514318722286085
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08514318722286085
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08514318722286085
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08514318722286085
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08514318722286085
PENTASOMY X	0.0025101940000000003	0.08514318722286085
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08514318722286085
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08514318722286085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08514318722286085
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08514318722286085
FILIPPI SYNDROME; FLPIS	0.002506059	0.08500293229468935
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08500293229468935
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08500293229468935
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08500293229468935
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08500293229468935
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08500293229468935
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08500293229468935
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08500293229468935
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.07980929400044706
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.07980929400044706
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.07980929400044706
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.07980929400044706
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.07980929400044706
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044706
SENGERS SYNDROME	0.00235294	0.07980929400044706
TEMPLE SYNDROME	0.00235294	0.07980929400044706
USHER SYNDROME, TYPE IF	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.07980929400044706
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.07980929400044706
BETHLEM MYOPATHY 1	0.00235294	0.07980929400044706
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.07980929400044706
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.07980929400044706
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.07980929400044706
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.07980929400044706
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.07980929400044706
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.07980929400044706
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.07980929400044706
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.07980929400044706
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.07980929400044706
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.07980929400044706
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.07980929400044706
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.07980929400044706
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.07980929400044706
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.07980929400044706
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.07980929400044706
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.07980929400044706
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.07980929400044706
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.07980929400044706
BRUNNER SYNDROME; BRNRS	0.00235294	0.07980929400044706
GILLESPIE SYNDROME; GLSP	0.00235294	0.07980929400044706
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.07980929400044706
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.07980929400044706
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.07980929400044706
AMISH NEMALINE MYOPATHY	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.07980929400044706
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.07980929400044706
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.07980929400044706
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.07980929400044706
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.07980929400044706
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.07980929400044706
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.07980929400044706
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.07980929400044706
SALIH MYOPATHY; SALMY	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.07980929400044706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.07980929400044706
TEMPLE SYNDROME	0.00235294	0.07980929400044706
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.07980929400044706
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.07980929400044706
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.07980929400044706
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.07980929400044706
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.07980929400044706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.07980929400044706
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044706
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.07980929400044706
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.07980929400044706
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.07980929400044706
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.07980929400044706
SILVER-RUSSELL SYNDROME	0.00235294	0.07980929400044706
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.07980929400044706
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.07980929400044706
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.07980929400044706
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.07980929400044706
MEVALONIC ACIDURIA; MEVA	0.002350604	0.07973005929374606
NOONAN SYNDROME 9; NS9	0.002350604	0.07973005929374606
NOONAN SYNDROME 2; NS2	0.002350604	0.07973005929374606
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.07973005929374606
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.07973005929374606
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.07973005929374606
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.07973005929374606
NOONAN SYNDROME 11; NS11	0.002350604	0.07973005929374606
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.07973005929374606
COLE-CARPENTER SYNDROME	0.002350604	0.07973005929374606
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.07973005929374606
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.07973005929374606
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.07973005929374606
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.07958980436557457
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.07958980436557457
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.07958980436557457
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.07958980436557457
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.07958980436557457
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.07958980436557457
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.07958980436557457
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.07958980436557457
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.07383731717252848
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252848
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.07383731717252848
48,XYYY SYNDROME	0.0021768739999999996	0.07383731717252848
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.07383731717252848
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252848
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.07383731717252848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.07383731717252848
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.07383731717252848
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.07383731717252848
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.07383731717252848
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.07383731717252848
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.07383731717252848
KNOBLOCH SYNDROME	0.002172739	0.07369706224435699
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.07369706224435699
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.07369706224435699
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.06950606861196464
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196464
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.06950606861196464
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.06950606861196464
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.06950606861196464
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.06950606861196464
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.06950606861196464
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.06950606861196464
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.06950606861196464
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.06950606861196464
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.06950606861196464
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.06950606861196464
OPSISMODYSPLASIA	0.00204918	0.06950606861196464
PYCNODYSOSTOSIS	0.00204918	0.06950606861196464
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.06950606861196464
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.06950606861196464
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.06950606861196464
CHITAYAT SYNDROME	0.00204918	0.06950606861196464
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.06950606861196464
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.06950606861196464
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196464
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.06950606861196464
JEUNE SYNDROME	0.00204918	0.06950606861196464
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.06950606861196464
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.06950606861196464
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.06950606861196464
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.06950606861196464
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.06950606861196464
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.06950606861196464
SMITH-MAGENIS SYNDROME	0.00204918	0.06950606861196464
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.06950606861196464
LARSEN SYNDROME	0.00204918	0.06950606861196464
2Q37 MONOSOMY	0.00204918	0.06950606861196464
WEILL-MARCHESANI SYNDROME	0.00204918	0.06950606861196464
SATOYOSHI SYNDROME	0.00204918	0.06950606861196464
TETRALOGY OF FALLOT	0.00204918	0.06950606861196464
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.06950606861196464
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.06950606861196464
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.06950606861196464
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.06950606861196464
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.06950606861196464
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196464
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.06950606861196464
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.06950606861196464
LOWRY-WOOD SYNDROME	0.00204918	0.06950606861196464
GRANGE SYNDROME; GRNG	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.06950606861196464
PROXIMAL SYMPHALANGISM	0.00204918	0.06950606861196464
RHYNS SYNDROME; RHYNS	0.00204918	0.06950606861196464
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.06950606861196464
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.06950606861196464
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.06950606861196464
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.06950606861196464
HYPOCHONDROPLASIA	0.00204918	0.06950606861196464
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196464
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.06950606861196464
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.06950606861196464
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.06950606861196464
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.06950606861196464
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.06950606861196464
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.06950606861196464
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.06950606861196464
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.06950606861196464
ROIFMAN SYNDROME	0.00204918	0.06950606861196464
FEINGOLD SYNDROME	0.00204918	0.06950606861196464
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.06950606861196464
PERIPHERAL DYSOSTOSIS	0.00204918	0.06950606861196464
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.06950606861196464
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.06950606861196464
ACROMICRIC DYSPLASIA	0.00204918	0.06950606861196464
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.06950606861196464
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.06950606861196464
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.06950606861196464
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.06950606861196464
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.06950606861196464
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.06950606861196464
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.06950606861196464
PYCNODYSOSTOSIS	0.00204918	0.06950606861196464
GREENBERG DYSPLASIA	0.00204918	0.06950606861196464
CAMPOMELIA, CUMMING TYPE	0.00204918	0.06950606861196464
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196464
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.06950606861196464
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.06950606861196464
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.06950606861196464
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.06950606861196464
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.06950606861196464
EIKEN SYNDROME	0.00204918	0.06950606861196464
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.06950606861196464
METATROPIC DYSPLASIA	0.00204918	0.06950606861196464
ENG-STROM SYNDROME	0.00204918	0.06950606861196464
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.06950606861196464
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.06950606861196464
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.06950606861196464
HEART-HAND SYNDROME TYPE 3	0.00204918	0.06950606861196464
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.06950606861196464
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.06950606861196464
HYPOCHONDROPLASIA	0.00204918	0.06950606861196464
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.06950606861196464
RADIO-RENAL SYNDROME	0.00204918	0.06950606861196464
EMERY-NELSON SYNDROME	0.00204918	0.06950606861196464
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.06950606861196464
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.06950606861196464
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.06950606861196464
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.06950606861196464
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.06950606861196464
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.06950606861196464
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.06950606861196464
ISOLATED BRACHYCEPHALY	0.00204918	0.06950606861196464
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.06950606861196464
COOKS SYNDROME	0.00204918	0.06950606861196464
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.06950606861196464
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.06950606861196464
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.06950606861196464
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196464
BANKI SYNDROME	0.00204918	0.06950606861196464
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.06950606861196464
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.06950606861196464
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.06950606861196464
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.06950606861196464
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.06950606861196464
SYNDACTYLY, TYPE V	0.00204918	0.06950606861196464
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.06950606861196464
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.06950606861196464
SYMPHALANGISM, DISTAL	0.00204918	0.06950606861196464
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.06950606861196464
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06663855914942085
MULIBREY NANISM	0.00196464	0.06663855914942085
ISOLATED TRIGONOCEPHALY	0.00196464	0.06663855914942085
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06663855914942085
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942085
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06663855914942085
MECKEL SYNDROME 12; MKS12	0.00196464	0.06663855914942085
RETINITIS PIGMENTOSA	0.00196464	0.06663855914942085
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942085
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06663855914942085
MARSHALL SYNDROME	0.00196464	0.06663855914942085
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06663855914942085
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA	0.00196464	0.06663855914942085
MEGALENCEPHALY	0.00196464	0.06663855914942085
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06663855914942085
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06663855914942085
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06663855914942085
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06663855914942085
PIEBALDISM	0.00196464	0.06663855914942085
ZECHI-CEIDE SYNDROME	0.00196464	0.06663855914942085
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06663855914942085
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06663855914942085
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06663855914942085
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06663855914942085
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06663855914942085
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06663855914942085
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06663855914942085
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06663855914942085
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942085
BOOMERANG DYSPLASIA	0.00196464	0.06663855914942085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06663855914942085
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06663855914942085
AXENFELD-RIEGER SYNDROME	0.00196464	0.06663855914942085
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06663855914942085
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06663855914942085
JUNG SYNDROME	0.00196464	0.06663855914942085
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06663855914942085
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06663855914942085
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942085
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06663855914942085
NON-DISTAL TRISOMY 10Q	0.00180505	0.061225431220306076
HARTSFIELD SYNDROME	0.00180505	0.061225431220306076
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.061225431220306076
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.061225431220306076
RESTRICTIVE DERMOPATHY	0.00180505	0.061225431220306076
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.061225431220306076
TRISOMY 1Q	0.00180505	0.061225431220306076
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.061225431220306076
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.061225431220306076
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.061225431220306076
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.061225431220306076
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.061225431220306076
PROTEUS-LIKE SYNDROME	0.00180505	0.061225431220306076
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.061225431220306076
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.061225431220306076
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.061225431220306076
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.061225431220306076
MARFAN SYNDROME; MFS	0.00180505	0.061225431220306076
RUVALCABA SYNDROME	0.00180505	0.061225431220306076
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.061225431220306076
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.061225431220306076
APERT SYNDROME	0.00180505	0.061225431220306076
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.061225431220306076
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.061225431220306076
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.061225431220306076
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.061225431220306076
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.061225431220306076
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.061225431220306076
CAT-EYE SYNDROME	0.00180505	0.061225431220306076
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.061225431220306076
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.061225431220306076
THOMAS SYNDROME	0.00180505	0.061225431220306076
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.061225431220306076
NOONAN SYNDROME 10; NS10	0.00180505	0.061225431220306076
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.061225431220306076
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.061225431220306076
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.061225431220306076
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.061225431220306076
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.061225431220306076
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.061225431220306076
MARFAN SYNDROME	0.00180505	0.061225431220306076
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.061225431220306076
PAI SYNDROME	0.00180505	0.061225431220306076
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.061225431220306076
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.061225431220306076
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05533268909908849
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05533268909908849
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.05533268909908849
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.05533268909908849
LICHTENSTEIN SYNDROME	0.00163132	0.05533268909908849
FETAL VALPROATE SYNDROME	0.00163132	0.05533268909908849
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.05533268909908849
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.05533268909908849
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.05533268909908849
SCHOLTE SYNDROME; SHLTS	0.00163132	0.05533268909908849
RENAL AGENESIS, BILATERAL	0.00163132	0.05533268909908849
MONOSOMY X	0.00163132	0.05533268909908849
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.05533268909908849
TURNER SYNDROME	0.00163132	0.05533268909908849
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.05533268909908849
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.05533268909908849
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.05533268909908849
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.05533268909908849
EPICANTHUS	0.00163132	0.05533268909908849
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.05533268909908849
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.05533268909908849
PENOSCROTAL TRANSPOSITION	0.00163132	0.05533268909908849
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05533268909908849
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.05533268909908849
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.05533268909908849
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.05533268909908849
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.05533268909908849
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.05533268909908849
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.05533268909908849
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.05533268909908849
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.05533268909908849
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.05533268909908849
MOSAIC MONOSOMY X	0.00163132	0.05533268909908849
JUBERG-MARSIDI SYNDROME	0.00163132	0.05533268909908849
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.05533268909908849
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.05533268909908849
BRITTLE CORNEA SYNDROME	0.00163132	0.05533268909908849
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.05533268909908849
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.05533268909908849
STICKLER SYNDROME	0.00163132	0.05533268909908849
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.05533268909908849
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.05533268909908849
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.05533268909908849
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.05533268909908849
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.05533268909908849
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.05533268909908849
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03686900121870848
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03686900121870848
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03686900121870848
CLASSIC PHENYLKETONURIA	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03686900121870848
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03686900121870848
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03686900121870848
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870848
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03686900121870848
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03686900121870848
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03686900121870848
ALSTRÖM SYNDROME	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03686900121870848
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03686900121870848
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.03686900121870848
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03686900121870848
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.03686900121870848
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03686900121870848
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03686900121870848
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03686900121870848
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03686900121870848
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03686900121870848
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870848
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.03686900121870848
NETHERTON SYNDROME	0.001086973	0.03686900121870848
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03686900121870848
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03686900121870848
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03686900121870848
ALG3-CDG	0.001086973	0.03686900121870848
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03686900121870848
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03686900121870848
ALG1-CDG	0.001086973	0.03686900121870848
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03686900121870848
GAUCHER DISEASE, TYPE II	0.001086973	0.03686900121870848
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.03686900121870848
MAPLE SYRUP URINE DISEASE	0.001086973	0.03686900121870848
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.03686900121870848
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03686900121870848
2P21 MICRODELETION SYNDROME	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03686900121870848
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.03686900121870848
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03686900121870848
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03686900121870848
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03686900121870848
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03686900121870848
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03686900121870848
COACH SYNDROME	0.001086973	0.03686900121870848
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.03686900121870848
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03686900121870848
HARTNUP DISORDER	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03686900121870848
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870848
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870848
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03686900121870848
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03686900121870848
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03686900121870848
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.03686900121870848
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03686900121870848
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03686900121870848
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03686900121870848
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03686900121870848
CRANIOPHARYNGIOMA	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03686900121870848
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.03686900121870848
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870848
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.03686900121870848
ELEJALDE DISEASE	0.001086973	0.03686900121870848
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03686900121870848
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03686900121870848
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870848
LEIGH SYNDROME; LS	0.001086973	0.03686900121870848
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03686900121870848
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870848
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03686900121870848
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03686900121870848
WYBURN-MASON SYNDROME	0.001086973	0.03686900121870848
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03686900121870848
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03686900121870848
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03686900121870848
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03686900121870848
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03686900121870848
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03686900121870848
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03686900121870848
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03686900121870848
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.03686900121870848
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03686900121870848
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.03686900121870848
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.03686900121870848
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03686900121870848
CITRULLINEMIA, CLASSIC	0.001086973	0.03686900121870848
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03686900121870848
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03686900121870848
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03686900121870848
PROPIONIC ACIDEMIA	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03686900121870848
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03686900121870848
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03686900121870848
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.03686900121870848
PHACE ASSOCIATION	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03686900121870848
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03686900121870848
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03686900121870848
LISSENCEPHALY 1; LIS1	0.001086973	0.03686900121870848
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03686900121870848
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03686900121870848
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03686900121870848
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.03686900121870848
CONGENITAL TOXOPLASMOSIS	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.03686900121870848
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03686900121870848
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03686900121870848
DPAGT1-CDG	0.001086973	0.03686900121870848
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03686900121870848
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03686900121870848
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03686900121870848
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03686900121870848
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03686900121870848
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03686900121870848
GALACTOSEMIA	0.001086973	0.03686900121870848
FUCOSIDOSIS	0.001086973	0.03686900121870848
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03686900121870848
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03686900121870848
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03686900121870848
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03686900121870848
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03686900121870848
HYDRANENCEPHALY	0.001086973	0.03686900121870848
TIMOTHY SYNDROME; TS	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03686900121870848
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.03686900121870848
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03686900121870848
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03686900121870848
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03686900121870848
ISOVALERIC ACIDEMIA	0.001086973	0.03686900121870848
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03686900121870848
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03686900121870848
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03686900121870848
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03686900121870848
SRD5A3-CDG	0.001086973	0.03686900121870848
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.03686900121870848
SCHINDLER DISEASE, TYPE I	0.001086973	0.03686900121870848
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03686900121870848
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03686900121870848
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03686900121870848
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03686900121870848
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03686900121870848
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03686900121870848
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.03686900121870848
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03686900121870848
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.03686900121870848
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.03686900121870848
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03686900121870848
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03686900121870848
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03686900121870848
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.03686900121870848
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03686900121870848
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03686900121870848
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03686900121870848
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03686900121870848
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870848
LISSENCEPHALY 4	0.001086973	0.03686900121870848
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03686900121870848
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.03686900121870848
17Q12 MICRODELETION SYNDROME	0.001086973	0.03686900121870848
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03686900121870848
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03686900121870848
XP21 MICRODELETION SYNDROME	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03686900121870848
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03686900121870848
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03686900121870848
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03686900121870848
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03686900121870848
RFT1-CDG	0.001086973	0.03686900121870848
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.03686900121870848
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03686900121870848
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03686900121870848
CITRULLINEMIA TYPE II	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.03686900121870848
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03686900121870848
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03686900121870848
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03686900121870848
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.03686900121870848
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03686900121870848
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03686900121870848
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03686900121870848
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03686900121870848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.03686900121870848
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03686900121870848
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.03686900121870848
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03686900121870848
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03686900121870848
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03686900121870848
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.03686900121870848
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03686900121870848
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03686900121870848
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.03686900121870848
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03686900121870848
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03686900121870848
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03686900121870848
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.03686900121870848
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03686900121870848
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.03686900121870848
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.03686900121870848
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03686900121870848
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.03686900121870848
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03686900121870848
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03686900121870848
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03686900121870848
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03686900121870848
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03686900121870848
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03686900121870848
EAST SYNDROME	0.001086973	0.03686900121870848
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.03686900121870848
GRISCELLI SYNDROME	0.001086973	0.03686900121870848
STT3A-CDG	0.001086973	0.03686900121870848
STT3B-CDG	0.001086973	0.03686900121870848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03686900121870848
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03686900121870848
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03686900121870848
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03686900121870848
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03686900121870848
COFFIN-SIRIS SYNDROME 5	0.001086973	0.03686900121870848
SULFOCYSTEINURIA	0.001086973	0.03686900121870848
KEUTEL SYNDROME	0.001086973	0.03686900121870848
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03686900121870848
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03686900121870848
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.03686900121870848
OPTIC PATHWAY GLIOMA	0.001086973	0.03686900121870848
ALG6-CDG	0.000545554	0.018504628073439992
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.018504628073439992
NAVAJO NEUROHEPATOPATHY	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.018504628073439992
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018504628073439992
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.018504628073439992
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.018504628073439992
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.018504628073439992
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.018504628073439992
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.018504628073439992
CONGENITAL VARICELLA SYNDROME	0.000545554	0.018504628073439992
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.018504628073439992
JOUBERT SYNDROME 6	0.000545554	0.018504628073439992
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.018504628073439992
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.018504628073439992
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.018504628073439992
JOUBERT SYNDROME 7	0.000545554	0.018504628073439992
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.018504628073439992
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.018504628073439992
JOUBERT SYNDROME 27	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.018504628073439992
JOUBERT SYNDROME 25	0.000545554	0.018504628073439992
8P23.1 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.018504628073439992
TYSHCHENKO SYNDROME	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.018504628073439992
ATHYREOSIS	0.000545554	0.018504628073439992
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.018504628073439992
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.018504628073439992
MUCOLIPIDOSIS IV; ML4	0.000545554	0.018504628073439992
REVESZ SYNDROME	0.000545554	0.018504628073439992
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.018504628073439992
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.018504628073439992
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
HOLOPROSENCEPHALY 11	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.018504628073439992
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.018504628073439992
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.018504628073439992
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.018504628073439992
TRANSALDOLASE DEFICIENCY	0.000545554	0.018504628073439992
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.018504628073439992
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.018504628073439992
SENIOR-LOKEN SYNDROME 9	0.000545554	0.018504628073439992
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.018504628073439992
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.018504628073439992
JOUBERT SYNDROME 28	0.000545554	0.018504628073439992
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.018504628073439992
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439992
NETHERTON SYNDROME; NETH	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA	0.000545554	0.018504628073439992
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.018504628073439992
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 26	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.018504628073439992
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.018504628073439992
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.018504628073439992
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439992
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.018504628073439992
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.018504628073439992
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.018504628073439992
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.018504628073439992
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439992
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.018504628073439992
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.018504628073439992
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.018504628073439992
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.018504628073439992
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.018504628073439992
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.018504628073439992
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.018504628073439992
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.018504628073439992
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.018504628073439992
JOUBERT SYNDROME 15	0.000545554	0.018504628073439992
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.018504628073439992
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.018504628073439992
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.018504628073439992
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.018504628073439992
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.018504628073439992
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.018504628073439992
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.018504628073439992
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.018504628073439992
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.018504628073439992
OROTIC ACIDURIA	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.018504628073439992
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.018504628073439992
WOLMAN DISEASE	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.018504628073439992
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.018504628073439992
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.018504628073439992
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.018504628073439992
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 8	0.000545554	0.018504628073439992
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.018504628073439992
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.018504628073439992
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.018504628073439992
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.018504628073439992
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.018504628073439992
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.018504628073439992
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.018504628073439992
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.018504628073439992
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.018504628073439992
PELLAGRA-LIKE SYNDROME	0.000545554	0.018504628073439992
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.018504628073439992
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.018504628073439992
WAARDENBURG-SHAH SYNDROME	0.000545554	0.018504628073439992
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.018504628073439992
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.018504628073439992
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.018504628073439992
FARBER DISEASE	0.000545554	0.018504628073439992
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.018504628073439992
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.018504628073439992
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.018504628073439992
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439992
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.018504628073439992
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.018504628073439992
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.018504628073439992
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.018504628073439992
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.018504628073439992
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.018504628073439992
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.018504628073439992
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.018504628073439992
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.018504628073439992
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.018504628073439992
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.018504628073439992
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 2	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.018504628073439992
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.018504628073439992
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.018504628073439992
CDAGS SYNDROME	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.018504628073439992
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.018504628073439992
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.018504628073439992
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.018504628073439992
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.018504628073439992
CURRY-JONES SYNDROME	0.000545554	0.018504628073439992
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.018504628073439992
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.018504628073439992
YUNIS-VARON SYNDROME	0.000545554	0.018504628073439992
LOWRY-MACLEAN SYNDROME	0.000545554	0.018504628073439992
PROPIONIC ACIDEMIA	0.000545554	0.018504628073439992
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.018504628073439992
ISOLATED PLAGIOCEPHALY	0.000545554	0.018504628073439992
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.018504628073439992
EPIDERMAL NEVUS SYNDROME	0.000545554	0.018504628073439992
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439992
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.018504628073439992
ARIMA SYNDROME	0.000545554	0.018504628073439992
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.018504628073439992
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.018504628073439992
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.018504628073439992
MECKEL SYNDROME 13; MKS13	0.000545554	0.018504628073439992
TRANSKETOLASE DEFICIENCY	0.000545554	0.018504628073439992
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.018504628073439992
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.018504628073439992
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.018504628073439992
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.018504628073439992
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.018504628073439992
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.018504628073439992
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.018504628073439992
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.018504628073439992
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.018504628073439992
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.018504628073439992
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.018504628073439992
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.018504628073439992
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.018504628073439992
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.018504628073439992
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.018504628073439992
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.018504628073439992
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.018504628073439992
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.018504628073439992
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.018504628073439992
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.018504628073439992
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.018504628073439992
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.018504628073439992
SENIOR-LOKEN SYNDROME	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.018504628073439992
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.018504628073439992
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.018504628073439992
SECKEL SYNDROME 8; SCKL8	0.000545554	0.018504628073439992
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.018504628073439992
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.018504628073439992
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.018504628073439992
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.018504628073439992
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.018504628073439992
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.018504628073439992
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.018504628073439992
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.018504628073439992
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.018504628073439992
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.018504628073439992
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.018504628073439992
SEPTOOPTIC DYSPLASIA	0.000545554	0.018504628073439992
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.018504628073439992
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.018504628073439992
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.018504628073439992
JOUBERT SYNDROME 21	0.000545554	0.018504628073439992
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.018504628073439992
USHER SYNDROME TYPE 1	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.018504628073439992
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.018504628073439992
AUSTRALIA ANTIGEN	0.000545554	0.018504628073439992
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.018504628073439992
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.018504628073439992
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.018504628073439992
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.018504628073439992
CURRARINO SYNDROME	0.000545554	0.018504628073439992
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.018504628073439992
THYROID HYPOPLASIA	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.018504628073439992
CULLER-JONES SYNDROME; CJS	0.000545554	0.018504628073439992
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.018504628073439992
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.018504628073439992
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439992
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.018504628073439992
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.018504628073439992
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.018504628073439992
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.018504628073439992
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.018504628073439992
LIG4 SYNDROME	0.000545554	0.018504628073439992
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.018504628073439992
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.018504628073439992
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.018504628073439992
MICROVILLUS INCLUSION DISEASE	0.000545554	0.018504628073439992
ALSTROM SYNDROME; ALMS	0.000545554	0.018504628073439992
SJÖGREN-LARSSON SYNDROME	0.000541419	0.01836437314526849
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.01836437314526849
ADDISON DISEASE	0.000541419	0.01836437314526849
FETAL GAUCHER DISEASE	0.000541419	0.01836437314526849
INSULINOMA	0.000541419	0.01836437314526849
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.01836437314526849
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.01836437314526849
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.01836437314526849
HADDAD SYNDROME	0.000541419	0.01836437314526849
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.01836437314526849
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.01836437314526849
PFEIFFER SYNDROME TYPE 3	0.000541419	0.01836437314526849
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.01836437314526849
LASSA FEVER	0.000541419	0.01836437314526849
NIPAH VIRUS DISEASE	0.000541419	0.01836437314526849
ENCEPHALITIS LETHARGICA	0.000541419	0.01836437314526849
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.01836437314526849
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.01836437314526849
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.01836437314526849
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.01836437314526849
TRIPLE A SYNDROME	0.000541419	0.01836437314526849
SYSTEMIC SCLEROSIS	0.000541419	0.01836437314526849
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.01836437314526849
SCRUB TYPHUS	0.000541419	0.01836437314526849
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.01836437314526849
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.01836437314526849
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.01836437314526849
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.01836437314526849
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.01836437314526849
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.01836437314526849
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.01836437314526849
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.01836437314526849
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.01836437314526849
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.01836437314526849
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.01836437314526849
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.01836437314526849
GURRIERI SYNDROME	0.000541419	0.01836437314526849
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.01836437314526849
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.01836437314526849
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.01836437314526849
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.01836437314526849
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.01836437314526849
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.01836437314526849
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.01836437314526849
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.01836437314526849
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.01836437314526849
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.01836437314526849
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.01836437314526849
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.01836437314526849
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.01836437314526849
THREONINEMIA	0.000541419	0.01836437314526849
THYROCEREBRORETINAL SYNDROME	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.01836437314526849
ADRENOLEUKODYSTROPHY	0.000541419	0.01836437314526849
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.01836437314526849
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.01836437314526849
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.01836437314526849
INCONTINENTIA PIGMENTI; IP	0.000541419	0.01836437314526849
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.01836437314526849
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.01836437314526849
IMMUNODEFICIENCY 47	0.000541419	0.01836437314526849
FABRY DISEASE	0.000541419	0.01836437314526849
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.01836437314526849
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.01836437314526849
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.01836437314526849
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.01836437314526849
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.01836437314526849
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.01836437314526849
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.01836437314526849
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.01836437314526849
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.01836437314526849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.01836437314526849
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.01836437314526849
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.01836437314526849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.01836437314526849
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.01836437314526849
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.01836437314526849
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.01836437314526849
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.01836437314526849
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.01836437314526849
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.01836437314526849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.01836437314526849
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.01836437314526849
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.01836437314526849
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.01836437314526849
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.01836437314526849
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.01836437314526849
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.01836437314526849
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.01836437314526849
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.01836437314526849
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.01836437314526849
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.01836437314526849
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.01836437314526849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.01836437314526849
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.01836437314526849
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.01836437314526849
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.01836437314526849
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.01836437314526849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.01836437314526849
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.01836437314526849
COWDEN SYNDROME 6; CWS6	0.000541419	0.01836437314526849
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.01836437314526849
PERRAULT SYNDROME 3	0.000541419	0.01836437314526849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.01836437314526849
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.01836437314526849
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.01836437314526849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.01836437314526849
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.01836437314526849
COWDEN SYNDROME 5; CWS5	0.000541419	0.01836437314526849
TAY-SACHS DISEASE; TSD	0.000541419	0.01836437314526849
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.01836437314526849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.01836437314526849
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.01836437314526849
SNEDDON SYNDROME	0.000541419	0.01836437314526849
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.01836437314526849
STURGE-WEBER SYNDROME	0.000541419	0.01836437314526849
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.01836437314526849
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.01836437314526849
ALEXANDER DISEASE	0.000541419	0.01836437314526849
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.01836437314526849
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.01836437314526849
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.01836437314526849
PARIETAL FORAMINA	0.000541419	0.01836437314526849
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.01836437314526849
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.01836437314526849
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.01836437314526849
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.01836437314526849
DIAMINOPENTANURIA	0.000541419	0.01836437314526849
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.01836437314526849
DYSOSTEOSCLEROSIS	0.000541419	0.01836437314526849
EPILEPSY-TELANGIECTASIA	0.000541419	0.01836437314526849
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.01836437314526849
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01836437314526849
FOUNTAIN SYNDROME	0.000541419	0.01836437314526849
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.01836437314526849
1P36 MICRODELETION SYNDROME	0.000541419	0.01836437314526849
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.01836437314526849
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.01836437314526849
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.01836437314526849
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.01836437314526849
PAPILLORENAL SYNDROME	0.000541419	0.01836437314526849
CROUZON SYNDROME	0.000541419	0.01836437314526849
DARIER-WHITE DISEASE; DAR	0.000541419	0.01836437314526849
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.01836437314526849
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.01836437314526849
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.01836437314526849
FLYNN-AIRD SYNDROME	0.000541419	0.01836437314526849
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.01836437314526849
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.01836437314526849
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.01836437314526849
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.01836437314526849
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.01836437314526849
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.01836437314526849
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.01836437314526849
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.01836437314526849
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.01836437314526849
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.01836437314526849
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.01836437314526849
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.01836437314526849
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.01836437314526849
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.01836437314526849
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.01836437314526849
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.01836437314526849
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.01836437314526849
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.01836437314526849
NEURAMINIDASE DEFICIENCY	0.000541419	0.01836437314526849
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.01836437314526849
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.01836437314526849
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01836437314526849
PHENYLKETONURIA	0.000541419	0.01836437314526849
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.01836437314526849
GITELMAN SYNDROME	0.000541419	0.01836437314526849
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.01836437314526849
RAMON SYNDROME	0.000541419	0.01836437314526849
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.01836437314526849
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.01836437314526849
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.01836437314526849
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01836437314526849
HYPERPROLINEMIA, TYPE II	0.000541419	0.01836437314526849
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.01836437314526849
BERNARD-SOULIER SYNDROME	0.000541419	0.01836437314526849
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.01836437314526849
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.01836437314526849
HYPER-BETA-ALANINEMIA	0.000541419	0.01836437314526849
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.01836437314526849
HYPERLYSINEMIA, TYPE I	0.000541419	0.01836437314526849
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.01836437314526849
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.01836437314526849
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.01836437314526849
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.01836437314526849
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.01836437314526849
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.01836437314526849
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.01836437314526849
KAPUR-TORIELLO SYNDROME	0.000541419	0.01836437314526849
KIFAFA SEIZURE DISORDER	0.000541419	0.01836437314526849
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.01836437314526849
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.01836437314526849
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.01836437314526849
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.01836437314526849
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.01836437314526849
WOLFRAM SYNDROME	0.000541419	0.01836437314526849
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.01836437314526849
TAKAYASU ARTERITIS	0.000541419	0.01836437314526849
MERCURY POISONING	0.000541419	0.01836437314526849
THYROCEREBRORENAL SYNDROME	0.000541419	0.01836437314526849
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.01836437314526849
VIRAL HEMORRHAGIC FEVER	0.000541419	0.01836437314526849
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.01836437314526849
WHIPPLE DISEASE	0.000541419	0.01836437314526849
WORSTER-DROUGHT SYNDROME	0.000541419	0.01836437314526849
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.01836437314526849
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.01836437314526849
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.01836437314526849
GALACTOSIALIDOSIS	0.000541419	0.01836437314526849
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.01836437314526849
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.01836437314526849
GLIOBLASTOMA	0.000541419	0.01836437314526849
ADIPOSIS DOLOROSA	0.000541419	0.01836437314526849
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.01836437314526849
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.01836437314526849
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.01836437314526849
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.01836437314526849
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.01836437314526849
TYROSINEMIA TYPE 2	0.000541419	0.01836437314526849
CONGENITAL RUBELLA SYNDROME	0.000541419	0.01836437314526849
CRONKHITE-CANADA SYNDROME	0.000541419	0.01836437314526849
PORENCEPHALY	0.000541419	0.01836437314526849
PROLACTINOMA	0.000541419	0.01836437314526849
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.01836437314526849
RAMON SYNDROME	0.000541419	0.01836437314526849
ISOLATED BILIARY ATRESIA	0.000541419	0.01836437314526849
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.01836437314526849
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.01836437314526849
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.01836437314526849
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.01836437314526849
NOCARDIOSIS	0.000541419	0.01836437314526849
LUJO HEMORRHAGIC FEVER	0.000541419	0.01836437314526849
EBOLA HEMORRHAGIC FEVER	0.000541419	0.01836437314526849
RIFT VALLEY FEVER	0.000541419	0.01836437314526849
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.01836437314526849
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.01836437314526849
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.01836437314526849
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.01836437314526849
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.01836437314526849
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.01836437314526849
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.01836437314526849
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.01836437314526849
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.01836437314526849
EPISODIC ATAXIA TYPE 3	0.000541419	0.01836437314526849
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.01836437314526849
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.01836437314526849
HEREDITARY COPROPORPHYRIA	0.000541419	0.01836437314526849
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.01836437314526849
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.01836437314526849
FAMILIAL THROMBOCYTOSIS	0.000541419	0.01836437314526849
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.01836437314526849
MPDU1-CDG	0.000541419	0.01836437314526849
ALG2-CDG	0.000541419	0.01836437314526849
ALG9-CDG	0.000541419	0.01836437314526849
MOGS-CDG	0.000541419	0.01836437314526849
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.01836437314526849
PORPHYRIA VARIEGATA	0.000541419	0.01836437314526849
GRISCELLI SYNDROME TYPE 2	0.000541419	0.01836437314526849
PORPHYRIA	0.000541419	0.01836437314526849
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.01836437314526849
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.01836437314526849
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01836437314526849
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.01836437314526849
HYPERPROLINEMIA TYPE 1	0.000541419	0.01836437314526849
HYPOPHOSPHATASIA	0.000541419	0.01836437314526849
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.01836437314526849
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.01836437314526849
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.01836437314526849
WHIM SYNDROME	0.000541419	0.01836437314526849
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.01836437314526849
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.01836437314526849
ONDINE SYNDROME	0.000541419	0.01836437314526849
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.01836437314526849
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.01836437314526849
MYASTHENIA GRAVIS	0.000541419	0.01836437314526849
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.01836437314526849
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.01836437314526849
RECURRENT ACUTE PANCREATITIS	0.000541419	0.01836437314526849
NEVUS COMEDONICUS SYNDROME	0.000541419	0.01836437314526849
LHERMITTE-DUCLOS DISEASE	0.000541419	0.01836437314526849
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01836437314526849
NASU-HAKOLA DISEASE	0.000541419	0.01836437314526849
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.01836437314526849
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.01836437314526849
ROMANO-WARD SYNDROME	0.000541419	0.01836437314526849
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.01836437314526849
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.01836437314526849
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.01836437314526849
BETA-MANNOSIDOSIS	0.000541419	0.01836437314526849
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.01836437314526849
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.01836437314526849
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.01836437314526849
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.01836437314526849
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.01836437314526849
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.01836437314526849
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.01836437314526849
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.01836437314526849
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.01836437314526849
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.01836437314526849
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.01836437314526849
CRISPONI SYNDROME	0.000541419	0.01836437314526849
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.01836437314526849
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.01836437314526849
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.01836437314526849
ROSAÏ-DORFMAN DISEASE	0.000541419	0.01836437314526849
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.01836437314526849
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.01836437314526849
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.01836437314526849
PSEUDO-TORCH SYNDROME 2	0.000541419	0.01836437314526849
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.01836437314526849
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.01836437314526849
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.01836437314526849
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.01836437314526849
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.01836437314526849
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.01836437314526849
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.01836437314526849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.01836437314526849
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.01836437314526849
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.01836437314526849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.01836437314526849
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.01836437314526849
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.01836437314526849
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.01836437314526849
MICROSPORIDIOSIS	0.000541419	0.01836437314526849
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.01836437314526849
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.01836437314526849
SANJAD-SAKATI SYNDROME	0.000541419	0.01836437314526849
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.01836437314526849
CITRULLINEMIA TYPE I	0.000541419	0.01836437314526849
AICA-RIBOSIDURIA	0.000541419	0.01836437314526849
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.01836437314526849
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.01836437314526849
MOYAMOYA DISEASE	0.000541419	0.01836437314526849
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.01836437314526849
MOYNAHAN SYNDROME	0.000541419	0.01836437314526849
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.01836437314526849
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.01836437314526849
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.01836437314526849
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.01836437314526849
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.01836437314526849
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.01836437314526849
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.01836437314526849
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.01836437314526849
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.01836437314526849
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.01836437314526849
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.01836437314526849
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.01836437314526849
CENTRAL DIABETES INSIPIDUS	0.000541419	0.01836437314526849
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.01836437314526849
FRONTAL ENCEPHALOCELE	0.000541419	0.01836437314526849
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.01836437314526849
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.01836437314526849
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.01836437314526849
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.01836437314526849
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.01836437314526849
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.01836437314526849
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.01836437314526849
CRIGLER-NAJJAR SYNDROME	0.000541419	0.01836437314526849
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.01836437314526849
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.01836437314526849
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.01836437314526849
EPISODIC ATAXIA TYPE 6	0.000541419	0.01836437314526849
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.01836437314526849
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.01836437314526849
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.01836437314526849
